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Abstract
Antibiotic resistance is a major health challenge because it limits the treatment options for common
infectious diseases and will cause 10 million deaths each year after 2050. There is an urgent need
to reduce the misuse of antibiotics and seek new classes of antibiotics that induce less or no
resistance. Despite the push for new therapeutics, there has been a precipitous decline in the
number of newly approved antibacterial drugs due to a limited understanding of how bacteria adapt
to the chemical stress stimuli. The development of antimicrobial resistance is especially true for
Gram-negative bacteria that develop resistance to antibiotics readily due to their unique highly
charged outer membrane. Structurally, the Gram-negative bacteria is highly asymmetric bilayer
that comprises of an inner leaflet of phospholipids and an outer leaflet of lipopolysaccharides.
Embedded in the bilayer are outer membrane proteins (OMPs) that form pores to allow passage of
nutrients and other small molecules through the cell wall. In addition to the outer membrane, the
Gram-negative bacteria have a thin peptidoglycan layer and an inner phospholipid membrane that
surrounds the cytosol. All potential small molecules have to navigate through all three layers of
the Gram-negative bacterial cell wall before targeting the cellular functions. There is, however,
limited understanding of the chemical specificity, structure, and functional aspects of each layer
in the cell wall. To enhance our understanding of the bacterial cell wall, we first developed
molecular models of ten commensal or human pathogenic bacterial species: Pseudomonas
aeruginosa, Escherichia coli, Helicobacter pylori, Porphyromonas gingivalis, Bacteroides
fragilis, Bordetella pertussis, Chlamydia trachomatis, Campylobacter jejuni, Neisseria
meningitidis, and Salmonella minnesota. Second, we studied the self-assembly of OMPs that in
some cases form trimers in the outer membranes to perform their function. In the third step, we
combined the outer membrane models and the OMPs to build a computational screening platform

to quantify the transport properties of molecules across a bacterial outer membrane. The goal of
the computational platform is to provide high-throughput screening of vast libraries of small
molecules that have the potential of being active antibacterial agents against Gram-negative
bacteria. A computational platform has merit to producing reliable first-round screening of
molecules at a fraction of the cost in the otherwise expensive drug-discovery pipeline.
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CHAPTER 1

BACKGROUND

1

1.1 Antibiotics Resistance
The discovery of antibiotics in the last century was one of the greatest achievements in the medical
world. Before that, a simple scratch may lead to death and infections were the most difficult
problem to overcome during surgery.1 From the 1920s to the 1980s, many different categories of
antibiotics were introduced to the market to make some common infections easy to treat.2
However, we are now at the same point as 70 years ago that infections are becoming harder to treat
when bacteria can protect themselves from antibiotics, and our most powerful antibiotics are
becoming ineffective, which is called antibiotic resistance.3-6 Antibiotic resistance occurs when
microorganisms gain the ability to stop the antimicrobial from working against it. Standard
treatments are becoming less effective, and infections are becoming harder to treat. Even though
the occurrence of antibiotic resistance is a natural process, the overuse and misuse of antibiotics
are becoming the primary reasons for accelerating this process to causes higher patient mortality
and treatment expenses.7 Consequently, many infectious diseases could no longer being effectively
treated by available antibiotics. Now, about 2 million people in United States have hospitalacquired infections, resulting in 99000 deaths per year.8 It has been estimated that by 2050, 10
million deaths will be caused annually by antibiotic resistance and US$ 100 trillion in losses if no
action is taken.9 So antibiotic resistance has become one of the biggest threats to human health. 1012

Even though the situation is very serious, the development of new antibiotics has slowed to a
standstill and cannot catch up with the emergence of resistant bacteria.13-17 The last discovery of
a new class of antibiotics was in 1987, since then there is a huge void in the history of antibiotics
development.18 Unfortunately, many major pharmaceutical companies are dropping antibiotics
development programs now, the development of one FDA-approved antibiotic needs at least 10
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years and over 1 billion dollars.19 Potential antibiotics need to be screened out from more than
thousands of small molecules, there is a lack of efficient screening technique, which can help lower
the investment and find out the most promising candidates.20 The low success rate makes the cost
higher than expectation, antibiotic resistance develops fast after new antibiotics being introduced,
which makes antibiotics a short-term drug and profits are also reduced.13, 15, 16. Workable guidance
of describing how to design antibiotic clinical trials from US Food and Drug Administration has
been long delayed.21 Even though there are some new antibiotics being introduced to the market,
physicians would prefer to use them when the worse situation happens because they are always
worry about the development of new resistance. These factors reduce the enthusiasm and
motivation of pharmaceutical companies to develop new antibiotics. So now, if we do not take
actions, we would have to face the same situation that there were no appropriate treatments for
infections.22-25

1.2 Mechanisms of Antibiotic Resistance
To better understand how to overcome antibiotic resistance, it is necessary to know how bacteria
develop antibiotic resistance. Bacteria, large group pf unicellular microorganisms, which are
thought to be the earliest life forms on earth.26-28 After a long period of evolution, bacteria have
gained the ability to adapt to hostile environment and sophisticated mechanisms of resistance to
some harmful naturally-produced molecules, which are the main source of antibiotics.2 Resistance
to one molecule can be accomplished by more than one biochemical pathway and bacteria can take
a variety of mechanisms to defend themselves from harmful molecules.7 To provide a
comprehensive way of explaining the mechanisms, people have categorized them as 1)
Modification of Antibiotic Molecule structures, 2) Modification of Antibiotics’ Target Sites
structures 3) Decreased Antibiotic Penetration 4) Efflux pump to extrude the antimicrobial
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compound.29 For example, resistance to β-lactams in Gram-negative bacteria is mainly because of
the effect of β-lactamases, which can break the structure of β-lactams.30-33 In Gram-positive
bacteria, the resistance is due to the modification of penicillin-binding proteins, which are the main
target of β-lactams.34-36 Besides these two mechanisms, Gram-negative bacteria have gained
advanced antibiotic resistance mechanisms due to their unique cell envelop structure, the special
cell wall prevent the entry of most harmful molecules and this cell wall has a group of proteins
called efflux pumps, which can pump out some toxic molecules that are in the periplasmic space
of Gram-negative bacteria.37-42 These advanced mechanisms make infections caused by Gramnegative bacteria even harder to treat. But this outer membrane and proteins are absent in Grampositive bacteria, which explains why most Gram-negative bacteria are more pathogenic. 43-45
1.2.1 Modification of Antibiotic Molecule structures
Both Gram-negative and Gram-positive bacteria can produce some specific enzymes that can add
some chemical moieties to the harmful compound or directly degrade these molecules.29, 46, 47 A
classic example of adding chemical moieties is aminoglycoside modifying enzymes (AMEs),
aminoglycoside is a traditional category of antibiotics that can inhibit protein synthesis in bacteria.
48, 49

AMEs can covalently modify the amino or hydroxyl groups. These modifications lead to

weaker affinity between the drug and its target due to the steric hindrance, resulting in higher MIC.
AMEs have become the leading cause of aminoglycoside resistance.50
In addition to modification, bacteria can also destroy the structure of some harmful compounds.
This is achieved by β- lactamases, which are able to destroy the amide bond of the β-lactam ring.
30, 31, 33

In order to prevent the effect of β- lactamases, new β-lactams were introduced to the market

with less susceptibility to β- lactamases. However, new β- lactamases were also appeared to be
able to hydrolyze the new β-lactams.32 Now even though people have developed more generations
4

of β-lactams, β- lactamases that can destroy any compounds were also found in bacteria. This is a
typical example of antibiotic driven adaptive bacterial evolution.51
1.2.2 Modification of Antibiotics’ Target Sites structures
Most antibiotics have their specific targets inside the bacteria to take effect by binding to them. 2,
52, 53

To interfere the binding of antibiotics and their targets, bacteria can protect the targets or

modify the structure of these targets to decrease the binding affinity.54-56 For example, a beststudied example of target protection mechanism involves tetracycline resistance determinants
Tet(M) and Tet(O).57-60 They are widely distributed among many different bacteria species. Tet(M)
and Tet(O) show different ways to protect the tetracycline target in ribosome.61 Tet(M) can directly
dislodge tetracycline from its binding site in ribosome by forming interaction between the domain
IV of the 16S rRNA and the tetracycline binding site, the formation of this interaction can also
change the conformation of ribosome to reduce the probability of rebinding. TetO has the same
binding site as tetracycline and thus is able to compete with tetracycline for the site to reduce the
binding of tetracycline.62-64
Moreover, the structure of target sites can also be altered by bacteria. This process is achieved by
enzymes. For example, the effect of erythromycin ribosomal methylation genes has been well
studied. An enzyme encoded by these genes can mono- or dimethylate an adenine residue in
position A 2058 of the domain V of the 23rRNA of the 50S ribosomal subunit, which is the main
binding site for macrolides, lincosamides, and streptogramin B antibiotics.65-68
1.2.3 Decreased Antibiotic Penetration
As mentioned above, most antibiotics have their intracellular bacterial hit targets. To get into the
bacteria, antibiotics have to penetrate the bacterial cell wall. The cell wall of both Gram-negative
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and Gram-positive bacteria can prevent the entry of antibiotics to reach their intracellular targets.69
It is worth noting that Gram-negative bacteria are becoming resistant to most available antibiotic
drugs.42, 70 The complicated outer membrane of Gram-negative bacteria was found to be able to
help them develop antibiotic resistance easily and quickly.71-74 The outer membrane of Gramnegative bacteria comprises lipopolysaccharides (LPS) as outer leaflet, mixture of phospholipids
as inner leaflet and outer membrane proteins (OMPs) as pores to allow transport of specific small
molecules.75, 76 The rigid outer membrane forms the first line of defense, which makes the Gramnegative bacteria much harder to treat than Gram-positive bacteria. Some hydrophilic antibiotics
such as β-lactams, tetracyclines and fluoroquinolones are found to be hard to penetrate the
hydrophobic outer membrane of Gram-negative bacteria.71 Vancomycin, which is another
example, cannot penetrate the outer membrane of Gram-negative bacteria, so it is ineffective to
treat infections caused by Gram-negative bacteria.77, 78
1.2.4 Efflux pumps
Efflux pumps are proteinaceous transporters found in bacterial cell envelop.79 There are 5 major
families of bacterial efflux pumps. 1) The major facilitator superfamily (MFS), 2) The resistancenodulation-cell division superfamily (RND), 3) The small multidrug resistance family (SMR), 4)
The ATP-binding cassette superfamily (ABC), 5) The Multi antimicrobial extrusion protein family
(MATE).80 MFS is mainly found in Gram-positive bacteria and RND is unique to Gram-negative
bacteria.81 In 1980, scientists found that in E.coli, its efflux pump was able to extrude
tetracycline.82 Since then, many different kinds of efflux pumps have been identified. Their ability
to pump toxic compounds out of bacterial cells have become another leading cause of the
development of antibiotic resistance.37, 80, 83, 84
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1.3 Current Study of Antibiotics Resistance
Bacteria mostly develop antibiotic resistance through these 4 mechanisms above. The decreased
antibiotic penetration was found to be the major difficulty for most antibiotics, which results in
poor effectiveness of most antibiotics. However, current drug design is largely based on the
interactions of the molecules with their target sites inside the cells, but the efficacy of antibiotics
also depends on the influx mediated by membrane lipids and porins85. Since most antibiotics need
to enter bacterial cells and bind to their target sites, they must be able to penetrate the bacterial cell
envelope. Hydrophobic antibiotics can take a lipid-mediated pathway and porins-mediate pathway
is major pathway for hydrophilic antibiotics74.
There have been number of experimental and computational studies conducted in understanding
the permeability of bacterial lipid membranes and the selectivity of porins. These high diversities
of lipid composition and porins types of bacterial outer membranes make huge differences of their
permeability. Understanding these differences would lead to more targeted antibiotics structure
design.
Nikado44 et al. found that some hydrophobic antibiotic such as aminoglycosides, macrolides,
rifamycins, novobiocin, fusidic acid, cationic peptides are able to penetrate the cell envelop by
diffuse through the lipids. However, the core oligosaccharide region of bacterial outer membrane
provides a barrier to hydrophobic antibiotics since it contains 6 to 10 sugars. Bacteria mutants with
truncated core show high sensitivity to lipophylic agents86.
Eren85 et al. summarized the substrate specificity of Outer Membrane Carboxylate Channels (Occ)
of Pseudomonas aeruginosa to help understand how this certain bacterium takes majority of small
molecules using these channels. They successfully proved that a carboxyl group in the substrates
is necessary for them to effectively transport Occ. They also identified the substrate specificities
7

of the two subfamilies of Occ, which includes 9 different porins. These results here revealed the
complexity of the selectivity of porins and the necessity of understanding it, which also lead to
rational design of novel antibiotics to fight against Pseudomonas aeruginosa.
Modi87 et al conducted x-ray crystallography, electrophysiology and molecular dynamics
simulations to study the outer membrane channels OprP and OprO with high similarity from
Pseudomonas aeruginosa. They identified the amino acids differences between these two channels
at the constriction region, which result in very different selectivity of these two channels. Double
mutants of these two porins were generated to understand the functions of these amino acids in
determining the channel specificity. These results they provided proposed another promising
strategy of modifying specific amino acids to obtain desired channel specificity.

1.4 Overcome Antibiotic Resistance using Computational approaches
Since the outer membrane of Gram-negative bacteria is the leading cause of antibiotic resistance,
and it has attracted a lot of attentions of scientists. Understanding the interactions between this
unique membrane and small molecules is essential to guide the development process of new
antibiotics. To achieve this goal, many potential candidates need to be tested from some small
molecules libraries, e.g. Microsource SPECTRUM Collection88, ChemBridge Diversity Set
Library89, etc. However, the traditional methods have many limitations, and they take longer time,
which indirectly leads to an increase in cost. To facilitate this process, computational approaches
should be employed to comprehensively understand the details at the molecular level and screen
out the most potential antibiotics candidates from these libraries to boost the drug discovery
pipeline. Even though there are a lot of experiments going on to study antibiotic resistance, there
are still many misunderstandings and unclear areas about the specific process of antibiotic
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resistance.5, 9, 11, 29, 46 Most experimental data can only give us macro conclusions, it is hard for
experiments to explore the detailed information in molecular level.
Recently, with the development of Computer-aided drug design (CADD), computational
approaches have been widely used to guide and accelerate the early-stage development of new
compounds more efficient and cheaply.90-92 Molecular dynamics (MD), which is a computer-based
simulation method to study chemical systems and provide physical behavior of each atom or
molecule in the system for nanoseconds to microseconds, can be employed to gain insights into
the actions of small molecules on bacterial outer membrane or membrane proteins in molecular
level to help develop robust antibiotics. 93-96
All-atom MD and Coarse-grained MD are being widely used to perform simulations. All-atom
MD provides us detailed interactions between each atom but needs more computing resources and
time, so it is too expensive for all-atom MD to achieve long simulation time and simulate
complicated systems.97 MD in coarse-grained (CG) level could help achieve longer time scale and
larger system sizes by merging several atoms into one bead to reduce the degree of freedom so
that people can explore more complex systems.98 Martini force field is a popular used CG force
field that provides us a variety of parameters of LPS, membrane lipids, amino acids, proteins,
solvents and ions.99-104 The details about how MD works will be discussed immediately in the next
chapter.
However, when we started, Martini force field did not provide parameters for bacterial LPS. To
fill this gap, we built force field parameters for 10 different common pathogenic or non-pathogenic
bacteria, available experimental data was used to validate our CG force field parameters. 105, 106
Proteins were also studied to show the ability Martini force field to reproduce the properties and
behavior of common membrane proteins.107 After that, we built our CG representation of
9

simulation systems comprising Gram-negative bacterial outer membrane with or without OMPs
embedded depending on the specific bacteria, target molecule and solvents to explore the
exhaustive transport behavior of target molecule through the membrane or OMPs into the
periplasmic space. The thermodynamic and kinetic data of the transport can be obtained by our
CG molecular simulations as well as the molecule-membrane/molecule-protein interactions. To
alleviate the burden of building new systems with different bacteria membranes, OMPs and small
molecules, we made an automatic simulation control algorithm to easily achieve our goals, which
is a computational automated screening platform that can quickly generate the data for further
analysis. These parameters of Gram-negative bacteria as well as the computational platform can
better guide the modification of existing antibiotics, design of new antibiotics and faster the
process of finding new antibiotics.
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CHAPTER 2

Basic Principles of Molecular Dynamics
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Understanding the microscopic interactions of atoms and molecules have always been a problem
in the scientific community due to their tiny size. The basic idea of MD simulation is to calculate
the interactions between the particles and integrate the equations of motion to explore the
microscopic properties and behavior of some systems that scientists have interested in.1 Classical
mechanics, statistical mechanics, thermal dynamics and kinetic theory are being used to obtain the
microscopic properties and corresponding macroscopic properties can be calculated by sampling
and averaging the microscopic behavior. 2
When performing MD simulations, all particles in a specific system can move and interact for a
fixed period of time, generating the trajectories by solving Newton's equations of motion.3 During
each step, the position, velocity, acceleration of every particle will be calculated and used to predict
the next position, velocity and acceleration. By repeating the process for all particles, the dynamic
evolution of the system can be revealed.4 The potential function, which is also known as force
field, is used to determine the forces acting on each particle. Potentials are defined to be able to
reproduce or mimic the structural or conformational changes to study a complex biological
system.1, 5, 6
In this chapter, a summary of key concepts and theoretical basis is introduced to clarify how MD
simulation works. Some commonly used algorithms, sample applications, limitations of MD,
software and force fields are also discussed briefly.
2.1 Equations of Motion
The basic idea of MD simulation is to solve the Newtown’s equations of motion.
𝐹𝑖 = 𝑚𝑖 𝑎𝑖

(1.1)

Where Fi is the net force acting on an atom or molecule, mi is the mass of the atom and a is the
acceleration.
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Alternatively,

mi

d 2 ri
= Fi
dt 2

(1.2)

The forces acting on the atoms are usually derived from a potential energy. And the potential
energy function U includes bonded and non-bonded elements as described below7.

𝑚𝑖

𝑑 2 𝑟𝑖
𝑑𝑡 2

=−

𝑑𝑈

(1.3)

𝑑𝑟𝑖

𝑈 = 𝑈𝑏𝑜𝑛𝑑𝑒𝑑 + 𝑈𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑
Firstly, we will consider the intramolecular bonding interactions including interatomic distance,
bend angles and torsion angles.
1

1

2

2

𝑟
𝜃
𝑈𝑏𝑜𝑛𝑑𝑒𝑑 = ∑𝑏𝑜𝑛𝑑𝑠 𝑘𝑖𝑗
(𝑟𝑖𝑗 − 𝑟𝑒𝑞 )2 + ∑𝑎𝑛𝑔𝑙𝑒𝑠 𝑘𝑖𝑗𝑘
(𝜃𝑖𝑗𝑘 − 𝜃𝑒𝑞 )2 +
1
2

𝛷,𝑚
∑𝑡𝑜𝑟𝑠𝑖𝑜𝑛 ∑𝑚 𝑘𝑖𝑗𝑘𝑙
(1 + cos(𝑚𝛷𝑖𝑗𝑘𝑙 − 𝛶𝑚)

(1.4)

Bonds typically involve the separation rij = | ri − rj| between adjacent pairs of atoms and a harmonic
form with specified equilibrium separation, the bend angle θijk are between continuous bond
vectors such as ri − rj and rj − rk, the torsion angles Φijkl are defined in terms of three connected
bonds. The torsional potential typically involves an expansion in periodic functions of order m =
1, 2, . . .
Non-bonded interactions include Van der Waals Potential and electric potential energy.
𝜎𝑖𝑗

12

𝑈𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑 = ∑𝑎𝑡𝑜𝑚 𝑝𝑎𝑖𝑟𝑠 4𝜀𝑖𝑗 [( )
𝑟
𝑖𝑗

𝜎𝑖𝑗

6

− ( ) ] + ∑𝑎𝑡𝑜𝑚 𝑝𝑎𝑖𝑟𝑠 𝑘
𝑟
𝑖𝑗

𝑞𝑖 𝑞𝑗
𝑟𝑖𝑗

(1.5)

The first term describes the Van der Waals repulsive and attractive interatomic forces in the form
of the Lennard – Jones 12-6 potential, and the send term is the Coulomb electrostatic potential.
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Now the force can be calculated using equation 1.3 when total potential energy is defined and
known. Together with the Taylor series expansions8:
1

𝑟𝑖 (𝑡0 + 𝛥𝑡) = 𝑟𝑖 (𝑡0 ) + 𝑣𝑖 (𝑡0 )𝛥𝑡 + 2 𝑎𝑖 (𝑡0 )(𝛥𝑡)2

1.6

1

𝑟𝑖 (𝑡0 − 𝛥𝑡) = 𝑟𝑖 (𝑡0 ) − 𝑣𝑖 (𝑡0 )𝛥𝑡 + 2 𝑎𝑖 (𝑡0 )(𝛥𝑡)2

1.7

1.6 + 1.7:
1
𝑟𝑖 (𝑡0 + 𝛥𝑡) = 𝑟𝑖 (𝑡0 ) + 𝑣𝑖 (𝑡0 )𝛥𝑡 + 𝑎𝑖 (𝑡0 )(𝛥𝑡)2
2
+

1

𝑟𝑖 (𝑡0 − 𝛥𝑡) = 𝑟𝑖 (𝑡0 ) − 𝑣𝑖 (𝑡0 )𝛥𝑡 + 2 𝑎𝑖 (𝑡0 )(𝛥𝑡)2

we can get
1

𝑟𝑖 (𝑡0 + 𝛥𝑡) = −𝑟𝑖 (𝑡0 − 𝛥𝑡) + 2𝑟𝑖 (𝑡0 ) + 2 𝑎𝑖 (𝑡0 )(𝛥𝑡)2
where r is the position, v is the velocity (the first derivative with respect to time), a is the
acceleration. −𝑟𝑖 (𝑡0 − 𝛥𝑡) is the position at (𝑡0 − 𝛥𝑡), 𝑟𝑖 (𝑡0 ) is the positions at 𝑡0 , 𝑎𝑖 is the
acceleration at 𝑡0 .
𝛥𝑡 is an important parameter that we define in MD simulations that is known. Mass of atom or
particle is known from periodic table of elements. Acceleration can be obtained from equation 1.1
because force is known when potential energy is defined. When starting a MD simulation, the
initial configuration tells us the initial 𝑟𝑖 (0), the distribution of velocities for all atoms at a certain
temperature we pre-set follow the Maxwell–Boltzmann distribution, which predicts the most
probable and average velocity.9 So after 𝛥𝑡, all atoms’ new position, net force, velocity and
acceleration can be determined. By defining the total simulation time, this step will be repeated
many time and finally the movement of atoms can be simulated.
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2.2 Force fields
For MD simulations, force fields provide potential functions mentioned in equation 1.3 and
parameter sets used in the potential functions to obtain the interactions between the atoms or
coarse-grained molecules in the systems.10 For most force fields, the parameter sets of potential
energy can be derived from experimental data and quantum mechanics. There are many different
force fields available now, such as OPLS (the Optimized potential for liquid simulation)11, ECEPP
(the empirical conformational energy program for peptides)12, AMBER (assisted model building
with energy refinement)13,

14

, CHARMM (chemistry at Harvard molecular mechanics)15,

GROMOS (GROningen MOlecular Simulation force field)16, Martini coarse grain force field17,
etc. Different force fields may differ in many aspects and also at different levels. These force fields
were developed by different research groups and each force field has their own emphasis on
specific biomolecules or systems. They all show different performance of simulating proteins,
organic solvents, solvents, nucleic acids, etc. Because the research groups who developed force
fields have their own research interests, the force fields were tuned for specific types of problems.
They are also compatible with different software. So the choice of force field depends on the actual
simulated system.18-20 Most force fields can be classified into two types: All-atom force field and
Coarse Grain force field.
2.2.1 All-atom force field
All-atom force field, as the name suggests, provides parameter sets for every single atom in a
system. GROMOS force field, which is an All-atom force field, was developed at University of
Groningen and Swiss Federal Institute of Technology. GROMOS force field is suitable to simulate
most small molecules, solvent and proteins. It can also be easily covert to coarse grain force field.
The potential functions of GROMOS force field is described as equation 1.4 and 1.5, which apply
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to most All-atom force fields even though they have different parameter sets from different sources
used in these potential functions.16 Some other all-atom force field hydrogen bonding potential
like AMBER force field.13 All-atom force field describes the detailed intermolecular and
intramolecular potential, so it provides accurate behavior of all atoms and molecules in a system.
However, due to extensive calculations of all-atom force fields, they cannot be applied to large
biological systems (> 100 nm) and some biological phenomenon that cost more than 100 ns.21
2.2.2 Coarse grain force field
Coarse-grained force field, on the contrary, is widely used in long-time simulations of
macromolecules such as lipids, sugars, sterols, polymers, proteins, nucleic acids, and multicomponent complexes. The MARTINI force field, which was developed by Marrink and
coworkers at the University of Groningen.17 After 2007, MARTINI force field was extended to a
variety of biomolecules that we needed to use in my work.22-27
MARTINI force field is one of the most popular coarse grain force field now. Based on all-atom
force field, MARTINI force field employs certain rules to coarse grain the atoms, on average 3 to
4 heavy atoms are mapped into one MARTINI coarse grained (CG) bead. This mapping reduces
the number of particles being simulated in a system and also the degree of freedom to reduce the
amount of calculations.
To accurately reproduce the interatomic and intraatomic interactions from all-atom force field, CG
beads in Martini force field are classified into 4 major types and 18 subtypes: polar (P), nompolar
(N), apolar (C) and charged (Q). Each major type has its own subtypes to represent specific
chemical units or functional groups based on their polarity. The combination of these 18 subtypes
can represent a lot of biomolecules. Because hydrogens are ignored in coarse grain force fields,
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based on the ability of forming hydrogen bonding, some functional groups can be divided into 4
kinds: d (donor). A (acceptor), da (both) and 0 (none).
MARTINI force field still uses similar bonded and non-bonded potential energy described in
equation 1.3, 1.4 and 1.5. Comparisons of MARTINI force field and some other all-atom force
fields have been done to verify the ability of MARTINI force field to reproduce the accurate
behavior of lipid bilayers, formation of vesicles, bacterial lipopolysaccharides membrane, etc. The
simplified CG model helps MARTINI force field to perform simulations of large systems ( > 100
nm) and longer time scale (> 100 ns), which is the best choice for my work to study the behavior
of complex membrane and proteins.28-31
2.3 Ensembles
In MD simulations, sometimes we have to keep some variables of the system constant to mimic
the real experimental conditions. Different statistical ensembles can be generated by controlling
the energy E, volume V, temperature T, pressure P, and number of particles N. After fixing one or
more variables mentioned above, structural, energetic, and dynamic properties can be obtained
based on the averages or the fluctuations of these fixed and unfixed variables. The most common
used ensembles in my study are NVT (constant number of particles, constant volume, constant
temperature)32 and NPT (constant number of particles, constant pressure, constant temperature)33.
NVT ensemble, also known as the canonical ensemble, the volume and temperature are fixed
during the simulation process. NVT ensemble can be obtained using direct temperature scaling at
the initialization stage and temperature-bath coupling during the simulation to control the system
temperature. Volume is always fixed during the whole process. NVT ensembles are mostly used
when performing conformational searches of molecules in vacuum regardless of defining volume,
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pressure, and density. In this condition, pressure is not a significant factor and NVT could provide
the advantage of less perturbation of the trajectory without coupling to a pressure bath.
NPT ensemble, known as isothermal-isobaric ensemble, the temperature and pressure are fixed
Isothermal-isobaric ensemble controls both temperature and pressure, which applies to most cases
of my study when pressure is an important factor and one atmosphere is always used to mimic the
realistic condition. In NPT ensemble, the volume of simulation systems is allowed to change to
adjust the pressure to preset value. This ensemble considers correct pressure, volume, and densities
are important factors. NPT ensemble can also be used to obtain another NVT ensemble when
desired temperature and pressure are needed to be achieved.
To achieve desired temperature and pressure, external heat and pressure bath controls are supplied,
they are also known as “thermostat” and “barostat”.34,
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There are many frequently-used

thermostat and barostat, such as Nosé-Hoover Thermostat36, Parrinello-Rahman barostat37,
Anderson Thermostat38 and Berendsen thermostat/barostat39, etc. They have their own advantages
and disadvantages in different situations.
The choice of thermostat and barostat depends on the actual situation and the original design
purpose of these algorithms. These methods were designed based on specific systems. Based on
other people’s experience and the systems I was studying, Berendsen thermostat and Berendsen
barostat were most frequently used to control the temperature and pressure as recommended by
the force field I was using and can be widely used for different systems. Another important reason
is the potential energy of the coarse-grained force field I was using was developed to take into
account the suitability of these types of thermostat and barostat. Some tests have been down to
prove the good performance of these two methods to achieve desired temperature and pressure
with less fluctuations.
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2.3.1 Berendsen thermostat
Berendsen thermostat is a coupling to an external ‘heat bath’ with given temperature TD. The
function of the heat bath is to compensate for missing or removed excess energy for the system.
The rate of change of the actual temperature TA is related to the preset temperature.
𝑑𝑇
𝑑𝑡

=

𝑇𝐷 −𝑇𝐴

1.8

𝜏

Based on the equation above, the effect of Berendsen thermostat is that a deviation of the system
temperature from initial TA is slowly corrected to the desired temperature TD. τ is a time constant
meaning the strength of the coupling between the system and the heat bath and should be preset
before starting a simulation, also known as relaxation time.
The temperature change between successive steps based on equation 1.8 is
∆𝑇 =

∆𝑡
𝜏

(𝑇𝐷 − 𝑇𝐴 )

1.9

A factor λ is defined as:
𝜆 = [1 +

∆𝑡 𝑇𝐷
(
𝜏 𝑇𝐴

− 1)]

1.10

Because the temperature of a system is corresponding to its kinetic energy, or velocity. So the
temperature of the system can be adjusted by scaling the velocity by the factor λ defined in equation
1.10.
𝑣𝑛𝑒𝑤 = 𝑣√𝜆
Based on experience before, when

∆𝑡
𝜏

= 0.0025. a good performance of Berendsen thermostat can

be achieved.
2.3.2 Berendsen barostat
Similar as thermostat, a system can be coupled to an external ‘pressure bath’ with given pressure
PD when using NPT ensemble. Now, the atomic coordinates and the box vectors are rescaled at
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each step instead of velocity in temperature coupling. It has the effect of a first-order kinetic
relaxation of the actual pressure PA towards a given pressure PD by
𝑑𝑃
𝑑𝑡

=

𝑃𝐷 −𝑃𝐴

1.11

𝜏

The rescaling of atomic coordinates and the box vectors are achieved by a factor μ, which is
defined as
𝜇𝑖𝑗 = 𝛿𝑖𝑗 −

Δ𝑡
𝛽 (𝑃
3𝜏 𝑖𝑗 𝐷

− 𝑃𝐴 )

1.12

Here δij is the Kronecker delta, τ is the pressure coupling time constant time constant and β is the
isothermal compressibility of the system, which can be obtained from experiments. For example,
when water at 1 atm and 300 K, β = 4.6 × 10−10 Pa−1 = 4.6 × 10−5 bar−1. These two parameters
must be set before starting the simulation.
2.4 Energy minimization
In MD simulations, the stable conformers of a system is necessary to perform the simulations and
understand the microscopic and macroscopic properties. When building simulation systems using
some computational chemistry software packages, the initial geometries are always not at the
stable state, some high energy conformers exist due to the molecular overlap, unreasonable
structure, etc. These high energy conformers can cause the simulations to terminate. In order to
remove these bad structures to get the stable conformers and normal simulations run, energy
minimization is performed before normal simulations. 40-42
Steepest descent algorithm is being used widely to energy-minimize the initial configuration. It
can remove some molecular overlap, bad contacts and adjust bond lengths and angle to suitable
values to create a relatively low energy initial conformation. The basic idea of steepest descent is
to find the net force in the systems based on the potential energy, then moving in the direction of
the force, just like walking straight down the hill in a geographical contour to find the conformer
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with lowest energy. The direction is determined by the maximum force between atoms. So from
the initial configuration, the system can quickly get rid out of the conformer with highest energy.
Each step, the new maximum force will be determined and the searching direction is changing
with the maximum force, by repeating the process, the maximum force is becoming smaller and
smaller until a preset threshold is achieved or close to zero, then the configuration at this moment
can be used as the starting configuration for next normal MD simulations.43, 44
2.5 Software to perform MD simulations: GROMACS
GROningen MAchine for Chemical Simulations (GROMACS) is a computational molecular
dynamics software package that is being used widely in the world.45 It was developed by
Biophysical Chemistry department of University of Groningen in 1991, and now it is maintained
by global universities and research centers. GROMACS is free and open-source software and one
of the most popular package for performing MD simulations for biological systems, such as
proteins, lipids, solvents, DNA/RNA and polymers.46 After years of development and update, a
rich set of calculation types, preparation and analysis tools are provided by GROMACS.44, 47 After
version 5, it is updated with several new and enhanced parallelization algorithms to significantly
improved computational efficiency.48 Moreover, Martini force field, which was developed in the
same university, uses the GROMACS infrastructure to implement coarse-grained physics models
that can reach much longer time scale and larger system size.
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Modeling diversity in structures of bacterial outer membrane lipids
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3.1 ABSTRACT
Lipopolysaccharides (LPS) are vital components of the outer membrane of Gram-negative
bacteria, and they act as extremely strong stimulators of innate immunity in diverse eukaryotic
species. The primary immunostimulatory center of the LPS molecule is lipid A—a disaccharidebound lipophilic domain. Considering the broad diversity in bacterial species, there are variations
in the lipid A structure and their immunogenic potency. In this work, we model the lipid A
structures of eight commensal or human pathogenic bacterial species: Salmonella minnesota,
Neisseria meningitidis, Porphyromonas gingivalis, Campylobacter jejuni, Bordetella pertussis,
Helicobacter pylori, Bacteroides fragilis, and Chlamydia trachomatis. The membrane properties
of lipid A from these bacterial species were characterized and compared using molecular
simulations. Molecular and structural insights provided reveal the diversity of in bacterial outer
membrane lipids and their contribution to human disease and immunity.
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3.2 INTRODUCTION
Gram-negative bacteria have evolved to protect themselves from hostile environments by
developing a protective outer membrane. Primary component of the outer membrane are the
lipopolysaccharide (LPS) macromolecules that due to their unique chemical structure provide a
negatively charged envelope around the bacterial cell.1 The LPS has three distinct domains—lipid
A, core oligosaccharide, and O-antigen polysaccharide. Although all three domains have integral
roles in the outer membrane, the amphiphilic lipid A domain plays a key role in anchoring the LPS
to the membrane via its hydrophobic interactions.2
Additionally, lipid A is a well-established endotoxin that stimulates innate immunity in diverse
eukaryotic species.3 Lipid A is highly conserved among bacterial species, and due to its distinctive
molecular structure it is recognized as a pathogen-associated molecule by Toll-like receptor
4/myeloid differentiation factor 2 (TLR4/MD2) present on host immune cells.4 As a response to
lipid A, the host cells secrete pro-inflammatory cytokines to neutralize the bacteria and their
endotoxic effects.
Structurally, lipid A molecule consists of a hydrophilic 1,4′-bisphosphorylated disaccharide head
and variable numbers of saturated fatty acid tails (Figure 3-1). The head unit consists of
hydrophiphic β(1→6)-linked D-glucosamine disaccharide head group with α phosphate group at
position 1 of the proximal, reducing glucosamine residue (GlcN I) and an ester bound phosphate
group at position 4′ of the distal, non-reducing glucosamine residue (GlcN II). The hydrophobic
tails comprise of four primary (R)-3-hydroxyacyl residues (labeled A, B, C and D) at the positions
2 and 3 as well as 2′ and 3′ via amide or ester linkages, along with four secondary fatty acid
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chains (A', B', C' and D'). The –R functional group (at position 6′) is the binding site of core
oligosaccharide domain.

Figure 3-1. Lipid A template structure.
Despite the well-defined structural template, lipid A structures vary among bacterial species.
Furthermore, to evade detection by the host immune system, bacteria undergo subtle modifications
to alter their quintessential primary lipid A template—in terms of glucosamine head group, degree
of phosphorylation, presence of phosphate substituents, as well as the nature, number, location,
and length of acyl chains.5,6 Often these structural modifications are employed as an active
response to changing environmental chemical stresses.7, 8 The structural modifications directly
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affect pathogenesis by changing outer membrane permeability and promoting resistance to
antimicrobial peptides. There is therefore, a need to understand structure property relationships
between the lipid A structures and the properties they confer to the outer membrane of a bacterial
species.
Experimental characterization of LPS remains challenging due to the complexity and
heterogeneity of the bacterial membrane. The isolation of a LPS macromolecule is non-trivial
considering the amphiphilic nature of lipid A that causes the formation of micelles. Determination
of high-resolution LPS structure requires iterative extractions followed by refinement and
fragmentation. Such advances in extraction methods coupled with improved characterization
techniques such as mass spectrometry (MS), matrix-assisted laser desorption/ionization (MALDI)
and electrospray ionization (ESI) have been invaluable. In order to expand beyond experimentally
determined static structural properties of these lipids, complementary computational approaches
are now being employed to assess the dynamical and thermodynamical properties of the bacterial
membranes.
Molecular simulations have become an indispensable tool to understand both the dynamic and
nanoscale organization of bacterial membrane structures. Although multiple computational
techniques have been employed to investigate these membranes, coarse-grain representation
provides an equitable balance between (1) the complexity and chemical specificity of membrane
lipids and (2) the length and timescales required to characterize these systems.9-11 In our previous
work, we adopted a multiscale approach to bridge atomistic and coarse-grained representations by
developing force field parameters for Pseudomonas aeruginosa LPS macromolecule.9
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In this work, we extend the MARTINI force field parameters10 for a library of eight commensal or
human pathogenic Gram-negative bacteria species: Helicobacter pylori, Porphyromonas
gingivalis, Bacteroides fragilis, Bordetella pertussis, Chlamydia trachomatis, Campylobacter
jejuni, Neisseria meningitidis, and Salmonella minnesota. After 80 independent simulations and
close to 150 µs of total simulation time, this library of representative bacterial lipids, provides an
excellent example of the structure-property relationship of lipid A structural modifications and the
impact they have on the bacterial outer membrane properties. The results highlight the role of acyl
chain lengths, number of chains, and phosphorylation state in regulating the phase transition
temperature of the membrane, along with the role of membrane composition and charge of the
counterions on membrane permeability. Prior to discussing the results, the background information
on the eight bacterial species, their differences in preferred habitat, and lipid A structure (Table 31) are briefly discussed.
Table 3-1 Summary of chemical structure of lipid A in various species of Gram-negative
bacteria. Labels A, A', B, B', C, C', D, and D' correspond to acyl chains shown in Figure 3-1.
Label P denotes the total number of phosphates.
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3.3 BACKGROUND
Helicobacter pylori
H. pylori are spiral, rod-shaped bacteria that live in the upper gastrointestinal tract. It is associated
with a variety of gastrointestinal diseases such as peptic ulcers, gastric adenocarcinoma and can
lead to stomach cancer.12 H pylori infection is found in over 50 percent of the world's population,
especially among the young, and is transmitted through direct human contact. H. pylori can often
be a lifelong infection in many of its hosts. The outer cell membrane of H. Pylori is similar to that
of other Gram-negative bacteria. The temperature range supporting H. Pylori’s growth is 307 K to
313 K, with the optimum temperature being 310 K, which is the average temperature of the human
body. The chemical structure of its lipid A has glucosamine β-(1-6) disaccharide with phosphate
at position 1 and four acyl chains (Figure 3-2). The acyl groups are (R)-3-hydroxyoctadecanoic
acid, (R)-3-hydroxyhexadecanoic acid, and (R)-3-(octadecanoyloxy)octadecanoic acid at the 2-, 3and 2′-positions, respectively.13
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Figure 3-2. Atomistic structure of Helicobacter pylori Lipid A.
Porphyromonas gingivalis
P. gingivalis is a non-motile, Gram-negative, endotoxic, anaerobic bacillus of the phylum
Bacteriodetes found in gingival tissue and in atheromatous plaque and thrives best at 310 K. It is
a suspected periodontal pathogen because it produces collagenase; however, about 25% of people
without periodontitis test positive for P. gingilvalis, while 21% of patients with periodontitis test
negative for P. gingivalis.61 The chemical structure of its lipid A comprises a hydrophilic β-(1,6)linked D-glucosamine disaccharide head that is monophosphorylated at position 1, and the
hydrophobic N- and/or O-acylation at positions 2, 3, 2′, and 3′ (Figure 3-3).15
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Figure 3-3. Atomistic structure of Porphyromonas gingivalis Lipid A.
Bacteroides fragilis
The anaerobic bacteria B. fragilis is part of the normal microflora of the human large intestine. It
is the most frequent cause of abdominal and wound infection post-surgical procedures of the
gastrointestinal or urogenital tract. B. fragilis is a unique enterobacteria with low endotoxicity,
primarily attributed due its monophosphorylated lipid A that has five acyl residues, which are
relatively long chains, each with 15-17 carbon atoms (Figure 3-4). The (R)-3hydroxyhexadecanoic acid and (R)-3-hydroxypentadecanoic acid residues are present at the
positions 3' and 3 of the distal GlcN and reducing GlcN groups, respectively. The amino group at
3' position carries (R)-3-(13-methyltetradecanoyloxy)-15-methylhexadecanoic acid and the pne at
position 3 carries (R)-3-hydroxyhexadecanoic acid.16
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Figure 3-4. Atomistic structure of Bacteroides fragilis Lipid A.
Bordetella pertussis
B. pertussis causes pertussis, a highly contagious respiratory infection commonly known as
whooping cough because of the characteristic sound patients make when they inhale. Transmission
between people most commonly occurs by coughing or sneezing. Its lipid A structure contains a
common bisphosphorylated disaccharide head group with hydroxytetradecanoic acid in the amide
as well at the 3′ position (Figure 3-5).17 The shorter acyl chains enable bacteria to escape the
receptor signaling system.
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Figure 3-5. Atomistic structure of Bordetella pertussis Lipid A.
Chlamydia trachomatis
C. trachomatis is the most common cause of sexually transmitted bacterial infection, with more
than 90 million new cases annually worldwide.18 C. trachomatis also is a cause of pelvic
inflammatory disease in women, increases transmission of HIV, and is a significant cause of
blindness in the developing world, where treatment is largely absent. Members of the Chlamydiae
genus are obligate intracellular parasites, and C. trachomatis is specifically reliant on human cells
to carry out its life cycle. The physiological effects of C. trachomatis, like all Gram-negative
bacteria, are invoked by its lipid A component. Mass spectrometry shows that the LPS of C.
trachomatis is composed mainly of a glucosamine disaccharide with five-fatty acid chains and one
phosphate head (Figure 3-6). The long fatty acid chains of C. trachomatis (up to 21 carbons) are
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anomalous to most Gram-negative bacteria lipid A components, and is thought to bring about its
relatively low toxicity.19,20

Figure 3-6. Atomistic structure of Chlamydia trachomatis Lipid A.
Campylobacter jejuni
C. jejuni is a microaerobic strain of proteobacteria with a helical shape. It is primarily responsible
for food borne bacterial gastroenteritis.21 C. jejuni is often found in animal feces and is transmitted
easily between animals and humans. Its capacity to form a biofilm increases the survival of C.
jejuni under detrimental conditions; when in a biofilm, the bacteria is one-thousand times more
resistant to disinfectants.22 The structure of C. jejuni lipid A is similar to others studies in this
work, except that one of the glucosamine residues of the lipid A backbone is replaced by of a
GlcN3N monosaccharide, a phosphorylated 2,3 diamino-2,3-dideoxy-D-glucose (GlcN3N)
disaccharide (Figure 3-7).
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Figure 3-7. Atomistic structure of Campylobacter jejuni Lipid A.
Neisseria meningitidis
N. meningitidis is a leading cause of bacterial meningitis and sepsis worldwide.23 Meningococcal
LPS has a bisphosphorylated disaccharide head group with 12:0(3-OH) acyl chains bound to each
of the two hydroxyl groups at positions 3 and 3', and 14:0(3- OH) acyl chains linked to the amino
groups at positions 2 and 2', and the hydroxyl groups of the amide-linked chains acylated by 12:0
carbon tails.24 Additionally, O-phosphorylethanolamine residues cap the phosphates at positions
1 and 4' (Figure 3-8).
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Figure 3-8. Atomistic structure of Neisseria meningitides Lipid A.
Salmonella minnesota
Typically S. minnesota, the second leading cause of intestinal infections, is transmitted through
ingestion of contaminated food. S. minnesota infection commonly occurs in the intestinal tract and
is associated with bloody diarrhea, abdominal cramps, and other related symptoms. Most
Salmonella serotypes are able to grow and thrive in environments whose temperature falls between
280 K to 321 K. S. minnesota lipid A has a typical 1,4′-bisphosphorylated disaccharide head group
with seven acyl chains that are 12–14 carbons in length. Position 2 and 3 have (R)-3-hydroxy fatty
acids and 2' and 3' have (R)-3-acyloxyacyl residues. Additionally hexadecanoic acid and
dodecanoic acid residues are on the (R)-3-hydroxytetradecanoic acid at positions 2 and 2',
respectively (Figure 3-9). 25
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Figure 3-9. Atomistic structure of Salmonella Minnesota Lipid A.

3.4 METHODS
3.4.1 Parameterization
The coarse-grain parameterization of the library of eight lipid A molecules is developed on the
Martini many-to-one mapping approach,10 and in most cases four heavy atoms are mapped into
one bead. The structural similarities in the disaccharide head groups and the dissimilarities in the
phosphorylation state and acyl chain patterns have been incorporated in the parameterization (see
Table 3-1). The proximal reducing (GlcN I) and non-reducing (GlcN II) glucosamine residues
were mapped individually to four beads with bead types ranging from P1–P4, based on the number
of hydroxyl groups. The phosphates at positions 1 and 4′ were assigned a Qa bead type with a unit
negative charge. The beads linking the acyl carbon chains via amide or ester linkages at positions
2, 3, 2′ and 3′ were assigned Na bead type. For N. meningitidis lipid A, the additional NH3+ groups
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linked to the phosphates were assigned Qd bead type. The acyl chain beads were assigned C1 bead
type. Figure 3-10 shows the CG mapping of N. meningitidis with bead assignments for the
disaccharide head group and six acyl chains. For the remaining lipids in the library, the CG
mapping of the acyl chains is also depicted in Figure 3-10.
Monovalent (Na+) or divalent (Ca2+) counterions were used to make the systems electrically
neutral. This ion parameterization accounts for the first hydration shell around the ion, and both
ions were assigned the Qd bead type. As in our previous work, no additional parameterization of
Ca2+ ions was performed, and the only difference in Na+ and Ca2+ was their net integral charge.
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Figure 3-10. Coarse-grained mapping scheme for lipid A tails of (A) N. meningitidis, (B) H. pylori, (C) P. gingivalis, (D) B. fragilis,
(E) B. pertussis, (F) C.trachomatis, (G) C. jejuni, and (H) S. minnesota. The bead types are shown in bold.
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3.4.2 Simulation and analysis details
Eight sets of simulations, which include variation of membrane composition, membrane size,
solvent, counterions, and temperature were performed for each of the eight membrane systems
(Tables 3-2 and 3-3). The simulations were performed using the molecular dynamics engine
GROMACS, version 5.1.2. The workflow of the simulations involved the initial construction of
membrane, energy minimization, short isothermal-isochoric (NVT) and isothermal-isobaric (NPT)
equilibrations runs, and long-production NPT runs.
Table 3-2 System Details of the Membrane Simulations Involving DPPE in the Inner Leafletα
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Table 3-3 System Details of the Membrane Simulations Involving a Complex Composition of
the Inner Leafletα

For each simulation run, the membrane was built using a python script, which is a locally modified
enhanced version insane, a versatile membrane-building tool routinely used in constructing coarsegrained membranes. The library of eight bacterial lipids have been coded in the freely distributed
insane script programmed in python. The workflow of the insane script was not changed from the
published version. The command line syntax for building the membranes, and the associated
topology files are provided in the Supporting Information.
The outer leaflet of the membrane is a mixture of lipid A and 1,2-dihexadecanoyl-sn-glycero-3phosphoethanolamine (DPPE) in 9:1 ratio for all seven sets. For the inner leaflet either a pure
DPPE (Sets I-V) or a mixture of DPPE, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
(POPE), and Cardiolipin (CDL2) in the ratio 7:2:1 (Set VI-VII) was used. POPE and CDL2 lipids
have −1 and −2 change, respectively. In generating the membranes, the total number of acyl chains
in the inner and outer leaflet were kept the same to avoid unphysical bending of the membrane.
The membranes were solvated with either standard water (W) or polarizable (PW) Martini water
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as specified (Table 3-2 and 3-3). All systems were made charge neutral by adding Na+ or Ca2+
counterions. Details of the solvent, number of ions, and membrane composition are provided.
Periodic boundary conditions were applied in all three dimensions.
Energy minimization was performed using the steepest-decent algorithm with a 20 fs time-step
until the maximum force on any bead was below the tolerance parameter of 10 kJmol−1nm−1. The
NVT and NPT simulation runs were performed for 0.2 µs. The production simulations were run for
at least 2 µs and up to 10 µs in some cases (Table 3-2 and 3-3) with a 20 fs time-step. Semiisotropic pressure coupling was used, and systems were maintained at 1 bar using the Berendsen
barostat with time constant, τp = 4.0 ps. Temperature was maintained at 310 K by independently
coupling the lipids and solvent to an external velocity rescaling thermostat with τT = 1.0 ps. The
heating scans were performed for a wider temperature range, varying from 275–360 K (Table 2
and 3). The neighbor list was updated every 25 steps using a cutoff equal to 1.4 and 1.2 nm for
short-range van der Waals and electrostatic cutoff, respectively. For simulations with polarizable
water, PME was used for the long-range electrostatics, with an electrostatic screening constant
εr = 2.5.
The structural and dynamic properties of the membranes were compared by computing area per
lipid, membrane thickness, density profiles, order parameters, and phase transition temperatures,
and diffusion coefficients. The membrane microstructure was quantified by the average area per
lipid (AL) and membrane thickness (DM), and hydrophobic thickness (DH). For bacterial
membranes, the AL values was computed by dividing the cross-sectional area of the membrane by
the number of lipid A molecules in the leaflet. Standard utilities available in the GROMACS
software suite were employed for all the quantities described above. To determine Tm, the
characteristic phase-transition temperature values for the model systems, we performed annealing
59

simulations starting from well-equilibrated configurations to mimic phase transition conditions.
The heating scans were performed over the 275–360 K temperature range with intermediate
temperatures of 292, 309, 326, and 343 K and 2 µs of simulation time.

3.5 RESULTS
3.5.1 Bonded parameters
The bond distances and bond angles analysis for all eight bacterial lipid A membranes was
performed using an identical protocol. For the ease of comparison, the lipid A analysis was divided
into two parts-the head group and acyl chains. Given that the proximal reducing (GlcN I) and nonreducing (GlcN II) glucosamine residues in the lipid A head group are the same or slightly different
(in C. jejuni) in the eight bacterial lipids, the average bond distance frequency distribution is very
similar (Figure 3-11). A unimodal frequency distribution of the bonded pairs centered at 0.30 ±
0.01 nm shows that the bonded pairs in a saccharide head group range between 0.29-0.39 nm both
in atomistic and CG simulations. A similar frequency distribution of the average internal angles
also shows a unimodal distribution centered at 75.2°±1.2°for all eight lipid A membranes (Figure
3-12). These results are consistent with analysis reported earlier for P. aeruginosa CG
parameterization.56 Although, the similarity in the bond and angle distribution is expected, the
results demonstrate the variations in the structures and the influence that phosphorylation state and
acylation pattern on the overall properties of the membrane.
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Figure 3-11. Average disaccharide head group bond distance frequency distribution for (A) H.
pylori (B) P. gingivalis, (C) B. fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N.
meningitides, and (H) S. Minnesota.
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Figure 3-12. Average disaccharide head group angle frequency distribution for (A) H. pylori (B)
P. gingivalis, (C) B. fragilis, (D) B.pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N.
meningitides, and (H) S. Minnesota.
For the acyl chains in all the systems, the average bond distance distribution shows unimodal curve
centered at 0.442 ± 0.012 nm (Figure 3-13). This average bond distance is +0.142 nm larger than
the head group bond distance because unlike the tails, head group beads are smaller and do not
always follow the 4-to-1 mapping prescription. The acyl chain bond angle distribution is unimodal
for all the lipid A membranes, but the location of the peak depends on the specific bacterial lipid
A structure (Figure 3-14). For example, lipid A structures that have 17-21 carbon acyls chains (H.
pylori, P. gingivalis, B. fragilis, and C. trachomatis) have peaks centered at 158 ±2°, while structures

with shorter 14-16 carbon acyl chains (C. jejuni, N. meningitidis, and S. minnesota) have peaks at 151
± 1°, and B. pertussis with shortest 10-14 carbon acyl chains has peak at 145°. Despite having
exactly same bond angle parameters for the acyl beads, the variation in the average angle with the
acyl chain length as significant implication on the membrane properties. It not only demonstrates
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that the CG parameterization is able to capture the molecular differences in these lipid A structures,
but it also validates that the membrane properties predicted by the force field are reliable.

Figure 3-13. Average acyl chain bond distance frequency distributions for (A) H. pylori, (B) P.
gingivalis, (C) B. fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N. meningitidis,
and (H) S. minnesota.
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Figure 3-14. Average acyl angle frequency distribution for (A) H. pylori (B) P. gingivalis, (C) B.
fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N. meningitides, and (H) S.
Minnesota.
The dihedral angles were not included for the disaccharide head group or the acyl chain beads.
This choice was based on the earlier reports in the literature, where including of dihedral angle
parameters required the use of an order of magnitude smaller time steps, not optimal for CG
simulations. Despite the absence of explicit dihedral angle parameters, the average dihedral angle
was computed for 2 µs trajectory. In all eight membranes (Set II) the acyl chains are linear with
average dihedral angle of 180°±11°or (0°±11) through the trajectory (Figure 3-15).

Figure 3-15. Dihedral angle fluctuations (degrees) as a function of simulation time for (A) H.
pylori (B) P. gingivalis, (C) B. fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N.
meningitides, and (H) S. Minnesota.

64

3.5.2 Area per lipid (AL) and phase-transition temperature (Tm)
In general, the AL for a lipid increases with increases in temperature as it acquires higher thermal
energy, and if varied over a long-enough temperature range, the lipids undergo phase transition
marked by a sharp increase in the AL versus T plot. In this work, the variation in AL for all eight
membranes was computed over 275-360 K temperature range (Figure 3-16) to determine the phase
transition melting temperature (Tm). To determine the Tm more precisely, the change in AL (ΔAL)
as a function of temperature was computed as a function of T, where the peak in the curve reflects
a sharp change in the area per lipid over a small change in temperature for an individual membrane
(Figure 3-17).

Figure 3-16. Area per lipid (AL) of Lipid A as a function of temperature for (A) Set II and (B) Set
VII bacterial outer membrane. Color scheme: H. pylori (brown), P. gingivalis (red), B. fragilis
(purple), B. pertussis (gray), C. trachomatis (black), C. jejuni (orange), N. meningitides (yellow),
and S. Minnesota (green).
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Figure 3-17. Phase transition temperature (Tm) for Set II membranes determined by the change in
the AL (nm2) versus T (K). The Tm values (K) are labeled for each curve. Color scheme for the
lines and labels: H. pylori (brown), P. gingivalis (red), B. fragilis (purple), B. pertussis (gray), C.
trachomatis (black), C. jejuni (orange), N. meningitides (yellow), and S. Minnesota (green).
As with the AL values of the lipids, characteristic changes in the lipid tails were observed for the
membranes below and above their Tm values. The tetra-acylated H. pylori lipid A has the smallest
AL value compared to the penta-, hexa- and hepta-acylated lipid A. The AL values of the pentaacylated lipid A (P. gingivalis, B. fragilis, C. trachomatis, and B. pertussis) are 1.2-1.3 nm2 in the
ordered phase, below their phase transition temperature. In the disordered phase, about 10 K above
the Tm, the AL values increase to 1.5–1.6 nm2. Upon increasing the number of tails to six the AL
values increase for both C. jejuni and N. meningitidis membranes. The computed AL values are in
the range 1.45–1.48 nm2 and 1.85–1.9 nm2, 10 K below and above their Tm, respectively. The
hepta-acylated S. minnesota, has the highest AL of 1.65 nm2 and 2.0–2.1 nm2 10 K below and above
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the Tm. Snapshots of the membranes below the Tm show ordered and fully extended lipid tails and
disordered and compacted lipid tails above the Tm (Figure 3-18).

Figure 3-18. Snapshots of thermal phase transition of (A) H. pylori, (B) P. gingivalis, (C) B.
fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N. meningitides, and (H) S.
minnesota in Set II. The panels show ordered phase (283 K, left) and disordered phase (350 K,
right) membrane structure. Color scheme: Lipid A head groups (orange); Lipid A acyl chains
(cyan); DPPE head group (blue); DPPE carbon tails (magenta).
Changing the lower leaflet composition (Set VI and VII) to include negatively charge POPG and
cardiolipin lipid resulted in lipid A AL values that were 0.2 nm2 larger than those in Set II. The
slight increase in lipid A AL is a direct consequence of the presence of charge in the lower leaflet,
which causes increase in the bilayer cross-sectional area.
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3.5.3 Membrane thickness
The DM values were computed by measuring the perpendicular distance between the planes formed
by the phosphate head groups of the top leaflet and the bottom leaflet. As expected DM is larger at
temperatures below Tm and smaller above the Tm. To capture this change in membrane structure,
thickness was computed as a function of temperature for all eight membranes (Figure 3-19). All
membranes, except B. pertussis, show ~0.51 nm decrease in DM after phase transition, which
matches with the change in thickness observed experimentally in S. minnesota over a 30 K
variation in temperature.26 For B. pertussis, this decrease is only about 0.24 nm because of short
10-12 carbon acyl chains relative to others (Table 3-4).

Figure 3-19. Membrane thickness (nm) as a function of T (K) for (A) H. pylori, (B) P. gingivalis,
(C) B. fragilis, (D) B. pertussis, (E) C. trachomatis, (F) C. jejuni, (G) N. meningitides, and (H) S.
Minnesota in Set II.
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Table 3-4 Key Properties of the Membranes and Comparison of the Phase Transition
Temperatures from Sets II and VII with Available Experimental Data

a

At T = 275 K. bReference 29. cReference 30.

The simulated S. minnesota DM was found 4.31 and 3.93 nm 10 K below and above the Tm, which
is in good agreement with the electron density profile for rough mutant lipopolysaccharides Re
(LPS Re) of S. Minnesota (strain R595). The experimentally reported upper leaflet head-group to
lower leaflet head-group distance of the bilayer is 4.29 nm at 293 K and 3.87 nm at 323 K.
3.5.4 Density profile
The distribution of individual components within the lamellar asymmetrical bilayers was
computed for all the membranes 10 K below their Tm. Because the lipids are in a thermal
equilibrium, they adopt highly variable instantaneous molecular orientations; therefore, density
profiles of all membrane components were calculated over 1 µs of the simulation trajectory to
account for ensemble averaging.
The density profiles computed for Set VI to determine the key feature of the membranes for
comparison (Figure 3-20). At each membrane interface, the Ca2+ ions interact with the lipid
headgroups and do not penetrate the hydrophobic tails of the outer and inner leaflets. The Ca2+ ion
density is more pronounced in the lipid A headgroups of N. meningitidis because of the presence
of additional phosphorylated residues that cap the phosphates at positions 1and 4’. This also
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explains the higher density of water surrounding the lipid A headgroups than phospholipids in the
inner leaflet. The counterion peaks in the density profile were used as a measure of the membrane
thickness. Additionally, the density profile of C1 beads (representing the acyl chains in both
leaflets) was plotted as a function of the membrane normal (z coordinate) as a measure of the
hydrophobic thickness (DH). The hydrophobic thickness lies in the 2.5 −3.3 nm range depending
on the number of carbons in the acyl chains. The C. trachomatis membrane with an average of 17
carbons in the acyl chains has the highest hydrophobic thickness of 3.3 nm, which can be an
important factor in determining the nature of the transmembrane porin proteins that can span the
relatively thick outer membrane. Additionally, the high hydrophobic thickness in C. trachomatis
also prevents the penetration of water deeper into the lipid A head groups.
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Figure 3-20. Density profile of key components of (A) H. pylori, (B) P. gingivalis, (C) B. fragilis,
(D) B. pertussis (E) C. trachomatis (F) C. jejuni, (G) N. meningitides, and (H) S. minnesota
membranes (Set VI). Color scheme: Water (blue); Ca2+ counter ions (green); Lipid A phosphates
(purple); DPPE head groups (red); DPPE carbon tails (black, dotted); and Lipid A carbon tails
(orange, dotted). The Ca2+counterion density is shown on the secondary y-axis. The trough
between the DPPE carbon tails (black, dotted) and Lipid A carbon tails (orange, dotted) profiles
marks the membrane mid-plane in each panel.
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3.5.5 Radial distribution function
The radial distribution functions (RDF) of Na+ and Ca2+ ions interacting with the negatively
charged phosphate and carboxyl groups of lipid A were calculated for all eight membranes (Figure
3-21). The curves for all membranes show similar trends, but notable is the peak for Ca2+carboxylate, which occurs at a longer distance (~1.3 nm) than the Na+-carboxylate peak (at 0.51
nm). The peak positions imply that Na+ is able to penetrate deeper into the membrane and interact
with carboxylate groups that lie below negatively charged phosphates.

Figure 3-21. RDFs for set II (Na+, dashed) and set VI (Ca2+, solid) for phosphate (black) and
carboxylate (red) for (A) H. pylori, (B) P. gingivalis, (C) B. fragilis, (D) B. pertussis, (E) C.
trachomatis, (F) C. jejuni, (G) N. meningitidis, and (H) S. minnesota.
3.5.6 Diffusion coefficient
The dynamical properties of the membrane are sensitive to the lipids that constitute the membrane
and the physiochemical aspects of the surrounding medium. Due to the inherent complexity of the
membranes it is often difficult to parse through these contributing factors individually. To mitigate
the variability among the membranes, the diffusion coefficients (D) of Set I membrane systems
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were computed, which have similar outer leaflet composition, pure DPPE inner leaflet, solvated
in water with monovalent Na+ counterions, and at T=275 K. The data shows the S. minnesota has
the lowest diffusion coefficient, while H. pylori has the about an order of magnitude higher
diffusion coefficient (Table 3-4). Although there is difference in the phosphorylation state of these
two lipids, the difference in D value is attributed primarily to the number of lipids and difference
in molecular weight. The hexa-acylated C. jejuni and N. meningitidis have D values in same order
of magnitude. The trend in the D values for the penta-acylated lipid A membranes (P. gingivalis, B.
fragilis, B. pertussis, and C. trachomatis), was less apparent, but the shortest acyl chain length B.

pertussis lipid A has the highest diffusion coefficient (Figure 3-22). As is evident from the AL and
D data, acyl chain addition or deletion has a significant effect on the membrane properties. The
acyl chain variability is an excellent example of a structure−property relationship showing how
bacteria can employ this attribute to adapt to their habitats.

Figure 3-22. Diffusion coefficient (cm2s−1) of for lipid A molecules (Set I) at 275 K.
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3.6 DISCUSSION
The complexity of Gram-negative bacterial outer membranes has been a limiting factor in the
computational modeling and characterization of these membranes. Until recently, the inherently
asymmetric outer membranes (with LPS/phospholipid leaflets) were simplified as symmetric
phospholipids in molecular simulations because of the lack of atomistic and coarse-grained force
field parametrization. The development of LPS models is in its infancy, with models available for
one or two bacterial species in atomistic and coarse-grained representations. There is therefore
limited molecular-level understanding of the effects of the number of acyl chains, the length of
acyl chains, and phosphorylation of a lipid on the membrane properties. The library of eight coarsegrained bacterial lipid models studied here will provide a systematic evaluation of the factors
contributing to the membrane properties.
3.6.1 Effect of number of acyl chains
Bacterial species adopt various acylation patterns to promote their survival by evading detection
by the host innate immune system. It has been shown that penta-, tetra,- and tri-acylated lipid A
surrogates stimulate a smaller immune response and lower cytokines levels compared to hexaacylated lipid A. Some bacteria actively modify lipid A in response to changes in temperature of
the host. An example is Yersinia pestis that produces hexa-acylated lipid A under ambient
conditions but shifts to a tetra-acylated form at temperatures close to mammalian body
temperature. In other cases, such as S. typhimurium and P. aeruginosa, acylation patterns are
modified by enzyme activity in response to hostile chemical stimuli, such as depletion of cationic
counterions, changes in pH, and presence of antimicrobial peptides, among others. The variability
in acyl chains permits up and down regulation of outer membrane permeability and structural
integrity, thus enhancing bacterial survival in harsh non-optimal environments.
74

The eight bacterial lipids studied here represent a range in lipid A structural diversity with 4–7
acyl chains. Analyzing the AL data (Table 3-4) 10 K below the phase transition (Tm −10 K) shows
that on an average each lipid tail contributes to ~0.24 nm2 to the area occupied by a lipid molecule.
While this rule-of-thumb holds well for the membranes below their phase transition temperature,
the contribution of the lipid tails increases to ~0.31 nm2 above the Tm in the disordered phase.
Additionally, increasing the number of chains decreases the diffusivity of the lipid. Diffusion
coefficient data from simulations of the eight lipid, under similar physiochemical conditions show
that hepta-acylated lipid A is an order of magnitude lower than the tetra-acylated surrogate, and
values of hexa- and penta-acylated lipid A are range between the two extremes (Figure 3-22).

3.6.2 Effect of acyl chain length

Membrane microstructure is dependent on the lipid-lipid interactions between adjacent molecules
and is intimately tied to the length of the acyl chains and the average hydrophobic thickness. A
membrane with a larger hydrophobic thickness experiences increased van der Waals attractions
between neighboring lipids, resulting in lower area per lipid and a higher phase transition
temperature. The data from the eight membranes studied here reflect the expected trend. Pair wise
comparisons of B. pertussis and C. trachomatis membranes, which have the shortest and longest
acyl chains of the group, show that C. trachomatis (with at least 2–6 additional carbons in the acyl
chains) has a higher hydrophobic thickness (∆DH = +0.6 nm), lower area per lipid (∆AL = −0.07
nm2), and a higher phase transition temperature (∆Tm = + 27 K) than does B. pertussis. Density
profiles of the membranes (Figure 3-23) show that the difference in the total membrane thickness
(∆DM = +0.6 nm) arises due to the hydrophobic thickness alone and not due to the disaccharide
head groups. In addition, comparing density profiles (Figure 3-20) of P. gingivalis and B. fragilis
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membranes, which have similar lipid A structures in terms of number of acyl chains,
phosphorylation, but differ only by one carbon in two of its acyl chain, have similar values for AL,
DM, DH, and Tm (Table 3-4).

Figure 3-23. Density profiles of key components of (A) B. pertussis and (B) C. trachomatis
membranes (set VI). Color scheme: water (blue); lipid A phosphates (purple); DPPE headgroups
(red); inner leaflet carbon tails (black, dotted); outer leaflet carbon tails (orange, dotted). The
Ca2+ counterion density (green) is shown on the secondary y-axis.
3.6.3 Effect of phosphorylation and counterions
The phosphorylation state of the disaccharide head group influences lipid A-mediated
endotoxicity. Bacteria species with missing phosphates are resistant to antimicrobial peptides and
are less active than the diphosphorylated lipids. For example, H. pylori consists of a tetra-acylated
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lipid A that lacks the 4ʹ-phosphate group to evade detection by Toll-like receptor 4 (TLR4) and
resists action by antimicrobial peptides.27 In Salmonella typhimurium, neutralizing the phosphates
results in increased antimicrobial resistance and decreased immunogenic response.28
Furthermore, the negatively charged phosphates act as coordination sites for divalent ions to
chelate adjacent LPS molecules. Comparison of phosphate-Ca2+ radial distribution functions,

gP-Ca2+ (r ) in H. pylori, C jejuni, and N. meningitidis, all show a predominant peak at

r = 0.5 nm,

irrespective of the number of phosphates on lipid A head groups (Figure 3-24). The separation
distance of 0.5 nm is particularly important because it is the signature of the closest non-bonded
distance between two CG beads. Unlike gP-Ca2+ (r), phosphate-phosphate (P-P) radial distribution
functions g P-P ( r ) clearly show differences in the phosphorylation states among these lipid A
structures. H. pylori with one phosphate (at position 1 of the disaccharide head group) shows a low
intensity P-P peak at 0.5 nm, mediated by the Ca2+ ions, but majority of the phosphates are less
organized illustrated by the broader peak centered at 0.8 nm (Figure 3-24A). On the other hand,
C. jejuni with two phosphate groups (at positions 1 and 4') shows well-defined peaks at 0.6 and
0.9 nm that correspond to the head-on intermolecular and the intramolecular P-P interactions,
respectively (Figure 3-24B). Finally, N. meningitidis with four phosphates (bonded pair at
positions 1 and 4') shows a bonded P-P peak at 0.3 nm, and broader peak centered at 0.9 nm. The
differences in the ionic charge density at the lipid A-water interface is shown in the inset snapshots
in Figure 3-24. As expected H. pylori snapshot shows lowest charge density, which is considered
to be the cause of higher resistant to cationic antimicrobial peptides.
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Figure 3-24. Lipid A headgroup phosphate −phosphate (gP −P(r); solid lines) and phosphate −Ca2+
counterion (gP −Ca2+(r); dashed lines) radial distribution functions for (A) H. pylori, (B) C.
jejuni, and (C) N. meningitidis. The inset images show top views of the lipid A headgroup
phosphates (green) and Ca2+ counterions (orange) from the surrounding medium.
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3.7 CONCLUSIONS
This work provides thermodynamic and dynamical properties of a diverse set of eight bacterial
membranes commensal or human pathogenic Gram-negative bacteria species: Helicobacter pylori,
Porphyromonas gingivalis, Bacteroides fragilis, Bordetella pertussis, Chlamydia trachomatis,
Campylobacter jejuni, Neisseria meningitidis, and Salmonella minnesota. This representative set
of Gram-negative bacteria have lipid A domains that differ in the degree of phosphorylation
presence of phosphate substituents, glucosamine head group as well as the nature, number,
location, and length of acyl chains. After multiple independent simulations for all membranes,
several key characteristics emerge. First, we find that on an average each lipid tail contributes
~0.24 nm2 to the total area of the lipid, therefore AL values of hepta-acylated S minneosta and tetraacylated H. pylori lipid A are in 7:4 ratio. Second, the membranes composed of longer acyl chain
lipid A have smaller AL and a higher phase transition temperature compared to their shorter acyl
chain counterparts. Third, membrane composition and charge of the inner leaflet can influence the
phase transition temperature of the membrane by 20-30 K. Four, the monovalent ions bury
themselves deeper in the membrane headgroups whereas the divalent ions are superficial and act
as chelating agents binding to the phosphates on adjacent lipid A molecules. The insights from the
work presented here coupled with the development of library of lipid A coarse-grained topology
will facilitate advances in knowledge-based design on antimicrobial agents.
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CHAPTER 4

Dynamics of OmpF trimer formation in the bacterial outer
membrane of Escherichia coli

Ma, H.; Khan, A.; Nangia, S., Dynamics of OmpF trimer formation in the bacterial outer membrane of Escherichia coli. Langmuir
2017, 34 (19), 5623-5634.
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4.1 ABSTRACT
The self-assembly of outer membrane protein F (OmpF) in the outer membrane of Escherichia
coli Gram-negative bacteria was studied using multiscale molecular dynamics simulations. To
accommodate the long timescale required for protein assembly, coarse-grained parameterization
of E. coli outer membrane lipids was first developed. The OmpF monomers formed stable dimers
at specific protein-protein interactions sites, exactly as identified in earlier literature. The dimer
intermediate was asymmetric but provided a template to form a symmetric trimer. Superposition
analysis of the self-assembled trimer with the X-ray crystal structure of the trimer available in the
protein data bank showed excellent agreement with global root-mean square deviation of less than
2.2 Å. The free energy change associated with dimer formation was −26±1 kcal mol−1, and for a
dimer to bind to a monomer and to form a trimer yielded −56±4 kcal mol−1. Based on
thermodynamic data, an alternate path to trimer formation via interaction of two dimers is also
presented.
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4.2 INTRODUCTION
Porins are barrel-shaped membrane proteins in the Gram-negative bacterial outer membrane; these
hydrophilic nanochannels permit the diffusion-mediated influx of nutrients through the otherwise
impermeable outer membrane.1-4 Porins are classified as non-specific channels because their low
affinity to bind to substrates results in the gradient-based diffusion of small substrates into the
bacterial cell. In contrast, specific protein channels are restrictive and have binding sites for
particular chemical substrates to facilitate selective transport. A typical Gram-negative bacterial
species may express several outer membrane channel proteins that differ structurally (lumen
diameter, number of strands, and oligomeric state) and channel functionally (specific or nonspecific).
In the bacterial outer membrane, porins encounter an asymmetric lipid environment with
lipopolysaccharide (LPS) in the outer leaflet and a mixture of phospholipids in the inner leaflet. 5
The LPS is a complex molecule that is composed of three domains—Lipid A, the core
oligosaccharide, and the O-antigen.6 Lipid A domain forms stabilizing non-bonded interactions
with the exposed hydrophobic residues on the porin surface. The four to seven saturated fatty acid
chains of Lipid A facilitate the tight packing of LPS molecules with protein channels to maintain
the outer membrane’s impermeability to hydrophobic substrates. The negatively charged core
oligosaccharide domain is cross-linked via divalent counterions to enhance outer membrane
stability and impermeability.7 The O-antigen consists of many repeats of an oligosaccharide unit
that extend outwards from the membrane into the bacterial surroundings.
In Escherichia coli, nutrient uptake is mediated by the non-specific outer membrane protein F
(OmpF), which consists of a homotrimeric β-barrel assembly.3,8 Each monomer has a cylindrical
topology formed by a 16-stranded peptide backbone arranged in an antiparallel motif. Its
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hydrophobic side-chain residues are exposed to membrane lipids, while the hydrophilic residues
form the lumen of the channel. The β-strands are connected via short turns (T1−T8) on the
intracellular side of the channel and longer loops (L1−L8) on the extracellular side. Loops interact
with LPS core domain to provide stability.9-12 In addition, L2 of each monomer participates in
stabilizing non-covalent interactions with the adjoining monomers within the trimeric assembly,
while the L3 buries into the lumen of the barrel to form a size-selective constriction zone for the
channel.13 The E. coli OmpF constriction zone is marked by positively and negatively charged
residues on opposing sides of the lumen, which are important for diffusion of charged substrates.
The high-resolution X-ray crystal structures of OmpF provide atomistic-level resolution of the
trimer,8 but these static structures lack the mechanistic and dynamic details governing
trimerization. Molecular dynamics (MD) simulations enable the extrapolation of static structures
to physiological events that can then be compared to experimental results. In previous molecular
dynamics (MD) simulations, the influence of the variability of the LPS environments on the
structure and dynamics of OmpF trimer was reported using all-atom MD simulations.14,15 Studies
of trimeric OmpF revealed deviations of dynamical structure relative to the crystal structure and
showed that L3 flexibility affected a change in pore cavity. Molecular dynamics simulations were
also successfully used to observe solute behavior and passage through OmpF, and findings
compared to experimental results.12,13 The recent development of new algorithms has enabled
research to simulate ion conduction directly using applied field MD simulations.16,17
Dimeric and monomeric states of OmpF also have been observed in vivo and in vitro
experiments.18-22 These findings suggest that the mechanism of OmpF formation proceeds in a
stepwise manner from monomers to dimers to trimers. In a computational study involving
dynamics of OmpF monomers in asymmetric phospholipid bilayers showed clustering and reduced
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mobility of the OmpFs in a crowded lipid environments,23 but did not specifically focus on the
mechanism of OmpF trimer formation. Other studies focused on the formation of OmpF assembly
revealed that the oligomerization occurs via specific protein-protein pair interactions.24-26 Each
OmpF monomer has two distinct patches centered at residues Glycine-19 (G19) and Glycine-135
(G135) that participate in oligomerization. A dimer is formed when G19 of an OmpF monomer
interfaces with G135ʹ patch of the OmpFʹ monomer. This dimer then interacts with the third
OmpFʺ monomer at the exposed G135 and G19ʹ patches to form G135-G19ʺ and G19ʹ-G135ʺ
interfaces to complete the OmpF-OmpFʹ-OmpFʺ trimer. Mutagenesis experiments have revealed
that perturbing these interfacial residues results in loss of oligomerization.24 In addition to
thermodynamic stability, oligomerization of OmpF provides structural support for the extracellular
loops. Niramitranon et al. showed that the OmpF trimer functions as a non-specific pore, but as a
monomer it becomes anion-selective due to the dislocation of the D113 side chain on L3 loop,
which blocks the cation pathway.15 Other research indicates that the change of the location of side
chains, the helices, or even the quaternary structure will result in porin malfunction.27 The selfassembly simulation results in conjunction to previous literature indicates that being a trimer in
E.coli’s outer membrane significantly decreases the structural flexibility of the OmpF and aids in
maintaining the pore function by allowing exchange of both cations and anions, which is essential
for E.coli survival.15 Several reports of computational studies involving the stability and
interactions of other trimeric bacterial porins based on from their trimeric X-ray crystallographic
structure.10-12,14-15,28-30 However, the stepwise assembly and molecular origins of OmpF
trimerization have not yet been studied in detail due to the inability to perform long-time scale
simulations with high fidelity to the underlying molecular structure.
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Here we report the development of a coarse-grain force field parameter set for E. coil outer
membrane lipids, which includes the Lipid A (LPA) and Lipid A with core (LPC). The force field
parameters are similar in spirit to the recently reported coarse-grained parameter sets for bacterial
lipids30-32 that reduce the degrees of freedom of the system and provides a computationally
affordable route to explore dynamics of molecular assemblies in microsecond timescales.33-40
Using the developed parameter set, we computed structural properties of LPA and LPC lipid
membranes, such as area per lipid, phase transition temperature, density profiles, hydrophobic
thickness, bond distances and bond angles analysis, and compared our findings to available
experimental and atomistic simulation results.
The outer membrane formed by the combination of the LPA in the outer leaflet and phospholipids
in the inner leaflet was used to study the oligomerization process of OmpF monomers to more
complex structures over tens of microseconds. We demonstrate the stepwise assembly of
monomeric OmpF into a stable dimer and subsequent interaction with another monomer to form a
stable trimer. The formation of OmpF trimer is a multibody interaction involving numerous
protein-protein and protein-lipid binding and unbinding events. In general, protein self-assembly
is a complex interplay of long-range (electrostatics, diffusivity, viscosity) and short-range
(hydrogen bonding, hydrophobic and hydrophilic interactions, and van der Waal interactions)
forces that drive the entire process from initial association to the final form via structural
rearrangements.
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4.3 METHODS
4.3.1 Parameterization

The E. coli lipid A head group (Figure 4-1) is a β(1→6)-linked D-glucosamine disaccharide linked
to C14 acyl carbon chains at positions 2 and 3 as well as 2′ and 3′ via amide or ester linkages. 41
The glucosamine residues (GlcN I and II) of the disaccharide head group are phosphorylated at
positions 1 and 4′. Nonhydroxy saturated C12 and C14 secondary carbon chains further esterify
the primary acyl chains at positions 2′ and 3′. The primary hydroxyl at position 6′ acts as the
binding site of the core LPS oligosaccharide domain. The core oligosaccharide domain is branched
and contains six to 10 hexoses (glucose and galactose units) with multiple anionic groups.6 The
divalent counterions act as chelating agents for the core anionic groups, diminish the electrostatic
repulsion between neighboring LPS molecules, and provide stability to the membrane.116 The
outermost O-antigen domain is also an oligosaccharide consisting of 1−40 repeat units that extend
into the surrounding medium.31,43 Overall, there is high variability in the length of core and Oantigen oligosaccharides in E. coli; however, only lipid A and partial core oligosaccharides are
essential for survival.

90

Figure 4-1. The chemical structure of E. coli lipid A domain. The head group is a β(1→6)-linked
D-glucosamine disaccharide linked to C14 acyl carbon chains at positions 2 and 3 as well as 2′
and 3′ via amide or ester linkages. The glucosamine residues (GlcN I and II) of the disaccharide
head group are phosphorylated at positions 1 and 4′. Nonhydroxy saturated C12 and C14
secondary carbon chains further esterify the primary acyl chains at positions 2′ and 3′. The
primary hydroxyl at position 6′ acts as the binding site of the core LPS oligosaccharide domain.

Here we develop the parameter set for lipid A and oligosaccharide core in the outer membrane of
E. coli (Tables S1−S4) using the coarse-graining approach reported previously.36,38 The coarsegrain parameterization of lipid A was developed based on MARTINI many-to-one mapping in
which on average four or three heavy atoms are mapped into one bead (Figure 4-2).44-46 Using the
Lipid A template reported earlier,36,38 each glucosamine unit was assigned four beads (P1, P2, P4,
P5) and each phosphate was mapped into one Qa bead type with a unit negative charge (Figure 43). The acyl chain beads were assigned C1 bead type. The frequency distribution of the average
bond lengths and angles of the acyl chains and glucose residues were computed (Figure 4-4 and
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4-5). Sodium and calcium ions were used as counter ions to make the whole system electrically
neutral. The E. coli parameter set adds to our library of nine bacterial species: Pseudomonas
aeruginosa, Helicobacter pylori, Porphyromonas gingivalis, Bacteroides fragilis, Bordetella
pertussis, Chlamydia trachomatis, Campylobacter jejuni, Neisseria meningitidis, and Salmonella
minnesota.

Figure 4-2. Representative chemical structure of E.coli (a) LPA, (b) LPC and (c) coarse grain
mapping of LPC. Panels (a) and (b) shows LPA and LPC phosphates (peach) and caroxylate
(orange; triangle) anionic groups, residue SYB and XYA (yellow; 3-(acetyl amino)-3-deoxy-Dglucose), LP1 (gray; 2-hydroxytetradecanoyl acid), LP2 (gray; dodecanoyl acid decyl ester) and
LP3 (gray; tetracanoyl acid decyl ester), and residues GAL (magenta; D-galactose), GLC
(magenta; D-glucose) and HEP(magenta; L-glycero-D-manno heptose), LKO and 0KO (gray; 3deoxy-D-manno-oct-2-ulosonic acid). The coarse-grain mapping (dashed lines) show bead
boundaries.
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Figure 4-3. (A) PO4, (B) XYA, (C) SYB, (D) LKO, (E) 0KO, (F) Gal 1, (G) Gal 2, (H) Glc1, (I)
Glc 2, (J) Hep 1,(K) Hep 2,(L) Hep 3,(M) LP1,(N) LP2, (O) LP3. The coarse grained mapping
scheme showing Martini beads of types Qa (black), P1 (yellow), P2 (blue), P4 (orange), P5
(green), N0 (purple), Na (light blue), and C1(grey) and overlaid on the atomistic structure in ball
and stick representation with carbon, oxygen, and linking bonds. Hydrogen atoms are not shown
for clarity.
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Figure 4-4. (A) Average acyl bond and B) angle frequency distribution. Average disaccharide
head group bond (C) and angle frequency distribution (D).
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Figure 4-5. Dihedral angle fluctuations (degrees) as a function of simulation time.

4.3.2 Simulation details

Asymmetric Membranes: We investigated three model membranes with varying level of lipid
complexity to capture the asymmetric behavior of E. coli membrane and the dynamics of OmpF
trimer self-assembly. The first membrane type (MT1) comprises of a Lipid A (LPA) in the outer
leaflet and DPPE in the inner leaflet. The second membrane type (MT2) is a combination of Lipid
A plus core (LPC) in the outer leaflet and DPPE in the inner leaflet. The third membrane type
(MT3) comprises of LPA:DPPE (9:1) outer leaflet, and a ratio 7:2:1 mixture of 1-hexadecanoyl2-(9Z-octadecenoyl)-sn-glycero-3

phosphoethanolamine

(POPE),

1-palmitoyl-2-oleoyl-sn-

glycero-3-phosphoglycerol (POPG), and cardiolipin (CDL2) in the inner leaflet, which most
closely mimics to the composition of the E. coli membrane. The outer leaflet LPA:DPPE lipid
ratio was maintained at 9:1 to the mimic the small concentrations of phospholipids that get
recruited from the lower leaflet to stabilize the membrane under stress.47
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The initial configuration of a coarse-grained membrane patches (10×10 nm2) were for built using
a locally modified version of python script called insane.py.48 The script uses a built-in library of
lipids, ions and solvents to generate systems of the MT1−MT3 lipid membrane (Table 4-1). The
E. coli LPA and LPC lipid templates were added, and the latest local version of the script is
available to researchers. The membranes were solvated with standard MARTINI water, and the
electroneutrality of the system was maintained using hydrated Na+ or Ca2+ counterions.
Table 4-1. Details of MT1−MT3 asymmetric membrane systems (without OmpF proteins).
Outer leaftet
Inner leaftet
Membrane
Counter
Type
Ion
LPA LPC DPPE
DPPE POPG CDL2
MT1a
77
231
Na+
MT1b
77
231
Na+
a
MT2
81
243
Na+
b
MT2
81
243
Na+
a
MT3
69
7
137
39
19
Ca2+
b
MT3
69
7
137
39
19
Ca2+
a
Simulations to determine equilibrium properties of the membrane
b
Simulations to determine the phase transition temperarure

No. of
water
ions
4358
154
4358
154
5831
486
5831
486
4607
107
4607
107

T (K)

t (𝜇s)

323
295-360
323
295-411
310
260-345

2
2
2
2
2
2

Membrane Protein Systems: The coarse-grained form of monomeric OmpF (pdb:4LSF) was
downloaded from the online MemprotMD server,49 which is an online repository for obtaining
equilibrated protein structures in coarse-grained representation. The modified insane script was
then used to insert the coarse-grained OmpF monomers in the desired membrane type (Table 4-2),
as well as add water and counterions. The monomers were placed in a square grid (2×2 or 3×3),
equidistant from each other and in random orientations (Figure 4-6a) to remove any
conformational bias during self-assembly. Simulations were performed in two stages, where the
OmpF monomers were initially position-restrained for 0.5 µs to equilibrate the surrounding lipids,
followed by unrestrained self-assembly production run in the second stage.
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Table 4-2. System details of OmpF-membrane simulations.
Outer leaftet
Inner leaftet
LPA LPC DPPE
DPPE POPG CDL2
1
MT1 124
12
384
2
MT3 124
12
244
68
36
3
MT3 81
9
162
45
18
4
MT2
72
8
224
5
MT2
81
9
252
6
MT3 207
22
410
117
58
7
MT2
225
25
445
129
63
8
MT1 234
26
728
9
MT1 216
24
672
a
Simulation time for each umbrella sampling window
System

MT

Protein
OmpF
4
4
9
4
9
3
3
2
3

No. of
water ions
31376 296
19663 436
13842 351
15629 480
15777 297
34520 683
23049 1641
25570 246
26370 234

t
T
(K) (𝜇s)
310 48
325 40
325 24
310 48
310 20
325 16
310
2
310 0.5a
310 0.5a

Figure 4-6. Simulation setup and self-assembly of OmpF trimer. (a) Side and top-view of a 3×3
grid of coarse-grained OmpF monomers (cyan, surface representation) in E. coli outer membrane
MT3 (System 3) comprised of LPA (yellow and white beads) outer leaflet and a complex inner
leaflet of DPPE (orange beads), POPG (blue beads), and CDL2 (magenta beads). Snaphots (top
view) of (b) stable dimer (System 1), (c) dimer (System 3), (d) fleeting dimer interaction (System
2), and (e) formation of OmpF trimer (System 6). In panels (b−e), the position of G19 (red bead)
and G135 (yellow bead) residues is highglighed; other components of the system are not shown
for clarity.
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Simulation set-up: The GROMACS molecular dynamics package50,51 (5.1.2) was used to perform
all simulations. Energy minimization was performed using the steepest-decent algorithm with a 20
fs time-step until the maximum force on any bead was below the tolerance parameter of 10
kJmol−1nm−1. Periodic boundary conditions were applied in all three dimensions. The NVT
(constant number of particles, volume, and temperature) and NPT (constant number of particles,
pressure, and temperature) equilibration runs were performed for 0.2 µs. Semi-isotropic pressure
coupling was used, and systems were maintained at 1 bar using the Berendsen barostat27 with time
constant, τp = 4.0 ps. Temperature was maintained at 310 or 325 K by independently coupling the
lipids, proteins, and the solvent to an external velocity rescaling thermostat with τT = 1.0 ps. The
neighbor list was updated every 25 steps using 1.4 and 1.2 nm for short-range van der Waals and
electrostatic cutoffs, respectively. The production NPT simulations were performed for 2 µs for
the membrane without proteins (Table 4-1) and between 2−48 µs for membranes with embedded
OmpF proteins (Table 4-2). For membranes without proteins, annealing simulations were
performed to obtain the phase transition temperatures; in brief, a short NPT was performed at 275
K followed by a heating scan from 275−360 K with a 15 K interval.
Potential of Mean Force (PMF) Calculations: To compute the PMF curves, we extracted the
self-assembled dimer and trimer from the equilibrium simulations (Systems 3 and 6, respectively)
and embedded them independently in 30×10 nm2 membrane patches of simple MT1 bilayer;
system 8 and 9, respectively. The MT1 lipids were equilibrated while keeping the proteins
position-restrained for 0.5 µs at 310 K. The restraints were then removed and pull simulations were
performed along the reaction coordinate defined by separation of the center of mass (COM) of the
interacting OmpFs while still embedded in MT1 bilayer. In case of both the dimer and the trimer,
one OmpF was pulled with respect to the COM of its position-restrained oligomeric counterpart.
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A harmonic potential with 1000 kJmol-1 nm2 force constant was used for the pull. A total of 30-40
independent umbrella sampling windows were extracted along the reaction coordinate for both
systems, and each window was simulated for 0.5 s. The weighted histogram analysis method
(WHAM) along with bootstrapping was used to extract the PMF curves.
General Analysis: Post simulation analyses were performed using in-built GROMACS utilities,
and external software suites such as YASARA52 for protein alignment with X-ray crystal structure
and CAVER41 for analysis and visualization of porin channels. The use of YASARA and CAVER
required reverse mapping of the OmpF from the CG representation to atomistic, which was
achieved by using backward.py script that uses a library of mapping definitions to reconstruct the
all-atom representation. Structural properties of the membranes such as area per lipid (AL), phase
transition temperature (Tm), membrane thickness (DM), and hydrophobic thickness (DH) were
computed. Molecular visualization and graphics were generated using VMD43 and YASARA.52

4.4 RESULTS AND DISCUSSION
4.4.1 Force field development and validation of membrane properties

Parameterization of E. coli outer membrane lipids is essential for examining OmpF assembly
because the protein-protein interactions occur in the membrane milieu. Unlike most biological
membranes that are symmetric, the asymmetric outer membrane comprising LPS-rich outer
leaflets and phospholipid-rich inner leaflets characteristic of Gram-negative bacteria contribute to
the membrane’s striking properties. The presence of LPS in the outer leaflet provides a highly
negatively charged hydrophilic nature to the bacterial membrane. Given that the complex outer
membrane environment influences the in vivo OmpF assembly, the E. coli LPS force field
parameter set should be accurately benchmarked before the in silico characterization of OmpF
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assembly. A well-parameterized membrane force field should provide agreement with the
available experimental data within the statistical uncertainty in the measurement.
4.4.1.1 Area per lipid

The AL quantifies the two-dimensional density of a membrane and captures the membrane phase
behavior.29,30 The correct prediction of AL value enables us to assess the quality of the
parameterization of the force field because the AL value is sensitive to molecular-level interactions
(lipid-lipid and lipid-water interface). The AL is a highly averaged equilibrium property of a
membrane and is often computationally expensive to calculate in an atomistic simulation due to
slow diffusion of lipids in a bilayer.23 Thus, a simplistic approach to compute AL is to divide the
cross-sectional area of the equilibrated membrane by the total number of lipids in each leaflet.
Using the CG parameter set developed here, we were able to equilibrate the E.coli outer membrane
and compute AL.
The AL values for MT1 and MT2 at 323 K after 2 s of equilibration are 1.39±0.02 and 1.53±0.06
nm2, respectively (Figure 4-7A). These values compare well to published AL values of 1.38−1.56
nm2 (Table 4-3).14,42,53 Given that AL is a function of membrane composition and temperature, it is
not surprising that there is a 0.18 nm2 variation in experimentally observed AL values. The AL for
LPC-rich MT2 should be higher than MT1 because the charged core oligosaccharide domain has
four additional negative charges per lipid A leading to higher electrostatic repulsion and larger
lipid-lipid separation, whereas in the LPA-rich MT1, the lipid tails predominantly interact via van
der Waals forces. Wu et al. using atomistic simulations also showed that AL increases with the
addition of core domain.14 The AL values for MT3 at 310 K after 2 s of equilibration is 1.86±0.06
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nm2; this value is higher than MT1 and MT2 (Table 4-3) because the heterogenity of the mixture
of lipids in the lower leaflets leads to looser packing and a higher area per lipid.38
A

B

C

Figure 4-7. (A) AL of outer leaflet lipids in MT1 (orange), MT2 (cyan), and MT3 (green)
membranes in (B) Effect of temperature on AL of outer membrane (same color scheme). (C)
Hydrophobic thickness of membrane in Systems 1 and 2.
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Table 4-3 Comparison of area per lipid of lipopolysachharides, phase transition temperature and
membrane thickness, and hydrophobic thickness data of MT1, MT2, and MT3 models with
available data in the literature.
MT1a,b
Properties

MT2 a,b

This work

Ref.

This work

Ref.

AL (nm2)

1.39±0.02

1.38/1.51/1.56

1.53±0.03

1.8

Tm (K)

319±2

317.5/314.15

328±1

-

DM (nm)

4.28±0.11

4

6.11±0.18

6.1/6.6

DH (nm)

2.86±0.04

2.3

2.50±0.09

2.2

MT3 a,b
This
Ref.
work
1.86±0.0
6
285±3
3.92±0.0
9
2.32±0.0
2.4
2

a

Simulations to determine equilibrium properties AL,DM, and DH
Annealing simulations to determine Tm

b

4.4.1.2 Phase transition temperature

The bacterial outer membrane can be in a gel (ordered) or liquid (disordered) phase depending
upon whether it’s characteristic phase transition temperature (Tm) is lower or higher than ambient
temperature. The phase transition is a rapid physical change in the membrane’s properties as a
function of temperature; it depends on multiple factors such as membrane composition, charge per
lipid, length and number of acyl chains, degree of unsaturation in lipid chains, and branching in
core domain. Each bacterial species has a characteristic Tm.38 Bacterial species are often able to
manipulate the makeup of their membrane lipids to adapt to the surrounding temperature for
survival.32,41
For an equilibrated membrane, the AL for a lipid increases with increases in temperature; therefore,
AL of a disordered liquid phase membrane is significantly larger than in gel phase due to the weaker
interactions between lipid A chains. The change in AL is gradual with temperature until Tm is
achieved, where gel-liquid phase change occurs. Once the temperature is above the Tm, a rapid
increase of AL occurs due to the phase change, which is captured from the change in the slope of
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AL versus T plot (Figure 4-7B). The three model membranes (MT1-MT3), have Tm ranging from
285 to 328 K based on the composition of outer and inner leaflets (Table 4-3). These results are
consistent with our earlier work, where Tm of LPA−complex or MT3 membrane of N. meningitidis
(hexacyl Lipid A) was lower (284±2) compared to LPA−DPPE or MT1 (324±3 K).38 The Tm of E.
coli LPS-DPPE membrane was observed to be 317.15 K in atomistic simulations.53 Naumann et
al. estimated Tm to be 314.15 K via Fourier-transform infrared spectroscopy.54 However, limited
data were reported about the Tm of complete outer membrane of E. coli with core oligosaccharide.
4.4.1.3 Other structural properties

Density profile of water, lipid tails, phosphate, and counter ions in MT1-MT3 systems were
computed (Figure 4-8) to examine the effect of LPA and LPC in the outer leaflet, and the influence
of a mixture of lipids in the lower leaflet. MT2 shows penetration of counter ions into the outer
LPC leaflet to interact with the core oligosaccharide phosphates. The difference between the
phosphate peaks of the outer and inner leaflets of the membrane was used to calculate the
membrane thickness of the membrane, which is 4.28±0.11 and 3.92±0.09 nm for MT1 and MT3,
respectively.
The MT2 membrane with the additional core domain in the outer leaflet lipids is considerably
thicker (6.11±0.18 nm) than the both MT1 and MT3, as expected. In comparison to the
Pseudomonas aeruginosa LPC-DPPE membrane type the membrane thickness value lies within
the previously reported 6.1-6.6 nm range.36 The density profile of water showed that the
membranes are impermeable to water as the density of water decreases to zero close to the
membrane mid-plane between 4-6 nm, although water can penetrate the core domain of LPA and
polar head groups of LPA and DPPE.
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Figure 4-8. Density profile of (a) MT1, (b) MT2 and (c) MT3. Color scheme: LPA (orange line)
and LPC (gray line); DPPE (red line); POPG (light red line); CDL2 (pink line); phosphates (green
line); ions (black line); water (blue line); inner DPPE leaflet (dark gray, shaded area) and outer
leaflet (light gray shaded area). The inset cartoon images of lipids in the shaded areas are provided
as a guide.
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The hydrophobic thickness of MT1 and MT2 bilayers was calculated from the density profile of
the acyl chains (Figure 4-7C). The MT1 bilayer, having only the lipid A domain in the outer leaflet,
has a larger (2.9 nm) hydrophobic thickness compared to the MT2 bilayer (2.5 nm) with the
additional core domain linked to lipid A. This observation demonstrates the inverse correlation of
the hydrophobic thickness with the AL, because higher area per lipid leads to smaller hydrophobic
thickness, as reported previously.14
4.4.2

OmpF self-assembly simulations

4.4.2.1 Dimer and trimer formation

The dynamics of OmpF assembly in the outer membrane revealed a two-step process involving
formation of an intermediate dimer that leads to the formation of a trimer. Several events involving
OmpF binding and unbinding were observed (Figure 4-6) as the proteins diffused through the MT1
and MT3 bilayers. The interactions in which monomers aggregated via the G19-G135 proteinprotein interface resulted in stable dimers (Figure 4-6b and 4-6c).The lifetime of the OmpF dimer
was dependent on the stability of the G19-G135 protein-protein interface. In most instances
monomers OmpF and OmpF' had fleeting interactions and did not lead to stable dimers (Figure 46d). Note that the superscript on OmpFʹ has been used to differentiate the two monomers only for
the clarity of the present discussion. To track formation of stable dimers, we computed the G19G135 separation distances for all interacting OmpF and OmpF' pairs. System 1, 2, and 3 formed
stable dimers and achieved an average minimum G19-G135 separation distance of 2.05 ± 0.05
(Figure 4-9). Other OmpF-OmpF' dimer interactions in which association did not occur via G19G135 interfaces, the G19-G135 pair separation remained larger than 2.05 ± 0.05 nm (Figure 4-9)
during the entire trajectory, and dimer association was short-lived (Figure 4-6d). In a series of
studies involving OmpF oligomerization, the G19 and G135 patches were identified as weakly
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stable regions of the OmpF β-barrel that interface with another monomer to acquire stability.
Naveed et al. showed that site-directed mutagenesis of G19 with energetically unfavorable
residues resulted in OmpF mutants with only monomers.24 Although simulations of the selfassembly of mutated OmpF are beyond the scope of the present work, the observed G19-G135
dimer is consistent with these previously reported results.

Figure 4-9. Distances between interfacial G19 and G135 residues in Fig.4-6b (purple), Fig.4-6c
(green) and Fig. 4-6d (blue).

Analysis of the number density plots of equilibrated lipids in system 3, showed a high density
corona of LPA molecules around the OmpF monomers (Figure 4-10a). The presence of LPA,
however, did not prevent the oligomerization or arrest diffusion of OmpF in the membrane (Figure
4b−d). The plots exhibit asymmetry in the localization of upper and lower leaflet lipids and their
adaptation to the OmpFs. The negatively charged head groups of LPA interact with the charged
loop regions of the OmpFs, but do not appear to stabilize the weakly stable G19 and G135 patches,
because in cases where a stable dimer is formed, the interacting OmpF interface gradually
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delipidates (Figure 4-10a). The lower leaflet DPPE molecules do not form a corona around the
OmpF monomer at the beginning of the simulation or after the dimer is formed (Figure 4-10b).
Similarly, the negatively charged POPG and CDL2 also do not form a high density corona, which
may be due to their low concentration in compared to DPPE in the lower leaflet (Figure 4-10 c−d).
The counterions interact with the charged loop domains and form hot spots at the dimer interface
due to localization of the OmpF loops.

Figure 4-10. Average partial number density of membrane components (a) LPA (outer leaflet),
(b) DPPE (inner leaflet), (c) POPG (inner leaflet), (d) CDL2 (inner leaflet), and (e) ions
(membrane surface) during two microsecond intervals of trimer formation (System 3).
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Structural analysis of the assembled dimer in System 3 shows lack of symmetry (Figure 4-11a). In
addition to the obvious asymmetry caused by the G19-G135 interface, the OmpF and OmpF'
channel lumens also have different diameters in the bottleneck region of 0.71 and 0.84 nm,
respectively. The overall root-mean-square deviations (RMSD) of individual monomers are also
different; the wider lumen monomer has higher flexibility (Figure 4-11b). Evidence of asymmetric
conductance through the dimeric pore has been reported previously.22 The asymmetry was
observed in all dimers, including those formed in Systems 1 and 2.

Figure 4-11. Reversed mapped snapshot of the self-assembled OmpF-OmpF' dimer (cyan;
surface representation) in System 3. Difference in (a) pore lumens (arrows) and (b) the overall
root-mean-square deviation of individual OmpF (orange) and OmpF' (black) units in the dimer as
a function of time. The G19 (red) and G135 (yellow) residues are shown as beads.

Furthermore, the asymmetric orientation of the dimer leaves two exposed patches, G135 on OmpF
and the G19 on OmpF', which together can accommodate a third OmpF chain to yield a trimer.
Simulation results show trimer formation after 16 µs (Figure 4-6e), where the OmpF-OmpF' dimer
gradually orients to interface with the OmpFʺ monomer to form the trimer (OmpF-OmpFʹ-OmpFʺ)
with C3 symmetry. The number density profile of the membrane lipids involved in trimer
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formation (System 6) shows a thin LPA corona around the OmpFs throughout the assembly
(Figure 4-12a). In contrast, the lower leaflet lipids do not show a preference to localize around the
trimer (Figure 4-12 b−d). The lipids form a tight seal around the trimer, which is evident from the
membranre mid-plane water number density profile that shows three distinct water filled channels
formed by the lumens of the OmpFs (Figure 4-12 e). The exposed OmpF loops electrostatically
attract counter ions and form a high density charge ring at the entrance of the trimer (Figure 412f).

Figure 4-12. Average partial number density of membrane components (a) LPA (outer leaflet),
(b) DPPE (inner leaflet), (c) POPG (inner leaflet), (d) CDL2 (inner leaflet), (e) water (membrane
midplane), and (f) ions (membrane surface) during two microsecond intervals of trimer
formation (System 6).
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The root mean square fluctuations (RMSF) of the amino acid residues were computed over the
ensemble of structures throughout the simulation (Figure 4-13a). The RMSF values provide unique
information about the oligomeric state of a protein. For example, dynamic residues exhibit larger
fluctuations from their reference structure and can be a signature of instability. Notably, the L2
residues in the OmpF dimer (Figure 4-13) show large fluctuations (0.4 nm) compared to the other
loops and the β-strand regions. Since L2 has a significant role in latching one monomer to its
neighbor, these large fluctuations become attenuated with trimer formation. Higher RMSF values
were observed for a few residues (6, 52 and 304), in the OmpF turns did not diminish upon
oligomerization. In the dimeric state, the OmpF-OmpFʹ contact is not fully established and the
G19-G135 intermonomer distance averages 2.05 nm, whereas in the fully formed trimer, the
separation distance reduces to 1.22 nm (Figure 4-13b). Evidence of high structural flexibility of
the monomer was obtained computing the RMSD of the structures in each oligomeric state (Figure
7c). The average RMSD values for the trajectory were consistently higher for the monomer (0.25
nm), followed by the dimer (0.20-21 nm), and then the trimer (0.18-0.19 nm), indicating higher
structure flexibility of monomer and a stable trimer, as expected. Another indicator of protein
structural flexibility is the radius of gyration (Rg), which refers to the distribution of the
components of an object around a center of mass of the molecule. The Rg provides a measure of
the compactness of OmpF porins in different oligomeric states (Figure 4-13d). The avagere Rg
values per monomer for monomeric, dimeric, and trimeric forms are 2.12, 2.09, and 2.04 nm,
respectively. The OmpF trimer with lowest Rg exhibits the tightest packing, consistent the RMSD
data.
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Figure 4-13. Dynamical properties of OmpF monomersa (orange, System 3), dimerb (green,
System 3) and trimercc (blue, System 6) during self-assembly. (a) Root-mean-square fluctuations
of backbone beads, (b) G19−G135 pair separation distance, (c) overall root-mean-square
deviation, and (d) Rg of the protein as a function of time. In panel (a), the shaded (light blue)
regions show the OmpF loop domains (L1−L8).
4.4.2.2 Comparison of self-assembled OmpF trimer and native structure

The detailed analysis of the structural and thermodynamic properties of the self-assembled OmpF
trimer with the X-ray crystal structure (pdb:4LSF) showed remarkable agreement. The global
RMSD of the assembled OmpF relative to X-ray structure was 2.161 Å, which is a relatively small
number indicating a very high similarity. Further comparison of the Cα-backbone for individual
monomers relative to the X-ray structure shows 1.99−2.11 Å RMSD (Table 4-4). The β-barrel,
loops, and turn motifs of the assembled structure also show small deviations ranging from 1.12–
1.89 Å. The extracellular loops are longer and have more flexibility than the periplasmic turns so
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it is expected that their deviations are slightly larger than the turns. Further, the total and buried
surface areas of the trimers were computed for comparison. The buried surface area provides a
measure of the surface-to-surface contacts between the monomers within the trimer. The total
surface area of the assembled trimer was 40483 Å2, which is within 0.4% of the crystal structure’s
surface area of 40296 Å2. Similarly, the buried surface area of the assembled trimer (8995 Å2) was
also found to be within 1.5% of the native structure (8861 Å2 ).
Table 4-4. RMSD (Å) of self-assembled trimer (OmpF-OmpFʹ-OmpFʺ) relative to the X-ray
crystal structure (pdb:4LSF).
Monomersa Cα
β-barrel Loops
Turns
OmpF
1.99
1.12
1.73
1.89
OmpFʹ
2.10
1.18
1.77
1.81
OmpFʺ
2.11
1.13
1.69
1.88
a
Labels OmpF, OmpFʹ, OmpFʺ represent the three monomers that consitute the trimer.
4.4.2.3 Mechanism and thermodynamics of OmpF oligomerization

The self-assembly simulations revealed the dynamics of the trimer formation, but not the
thermodynamics of the process. To compute the thermodynamic stability of a dimer relative to
well-separated monomers, umbrella-sampling simulations were performed to dissociate the dimer
along the intermonomer separation coordinates. Similarly, the trimer was dissociated into a dimer
and a monomer. The dissociation of the dimer into two well-separated monomers required 26±1
kcal/mol, whereas dissociating a trimer into a dimer and monomer required 56±4 kcal/mol (Figure
4-14). Both simulations were performed while the proteins were embedded in LPA-phospholipid
membrane to capture the contribution from the asymmetric membrane environment. The
importance of membrane asymmetry has been emphasized in prior computational and in vivo
experimental studies involving protein folding and assembly.55-56
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Figure 4-14. Potential of mean force profiles for unbinding of the dimer (System 8) and trimer
(System 9) interfaces along the interseparation distance coordinate of the interacting pair. Error
bars calculated by Bayesian bootstrapping method are shown in the same color.

The thermodynamic stability of the dimer relative to monomers in the LPA-phospholipid
membrane indicates that the first step of the assembly process is the pairing of monomers. This
finding is consistent with the in vitro and in vivo ability of OMPs to form oligomers in the outer
membrane.22 Our results indicate that two monomers diffusing independently in the outer
membrane will form a stable dimer if they interact in the correct orientation. Interestingly,
thermodynamic data suggests that the further oligomerization of dimer to trimer can occur via two
different pathways: (a) Path I—the dimer interacts with a monomer to form the trimer (observed
in the simulations), and (b) Path II—the dimer interacts with another dimer to form a trimer and a
lone monomer (not observed in the limited simulation time). Although both paths are feasible
(Figure 4-15), Path II involves interaction between two slowly diffusing dimers that need to
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interact in the correct orientation to cause dissociation of one dimer in the process of forming a
trimer. The transition state for dimer-dimer interaction is expected to have a higher barrier. It is,
therefore, not entirely surprising that Path II was not observed in the 48 µs of simulation time.
However, another factor contributing to the choice of Path I or II would be the relative population
of monomers versus dimers in the bacterial membrane during oligomerization.

Figure 4-15. A schematic showing two possible pathways that lead to OmpF trimer formation.

4.4.2.4 Interaction of OmpF timer with membrane lipids

The membrane lipids provide a tight seal around the OmpF to direct the passage of water-soluble
nutrients through the trimeric nanochannels. The lipid A tails interact with the hydrophobic
residues of the β-barrel and the phosphates in the lipid A head groups interact with the positively
charged residues in porin loops. In vitro experiments have demonstrated that irrespective of the
core and O-antigen domains, lipid A binds to the OmpF trimer. The cross-sectional view of the
membrane midplane shows a water-filled OmpF lumen with water absent in the rest of membrane
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(Figure 4-12). The water density profile shows the distinct footprint of homotrimeric water
channels for LPC membrane (Figure 4-12e). Overall, we observe that like many integral membrane
proteins, OmpF porins assemble to form oligomeric structures in lipid microenvironment. Despite
the extensive hydrogen-bond network that maintains the β-barrel tertiary structure of the OmpF,
specific weakly stable regions of the β-barrel remain, which drive OmpF oligomerization. OmpF
has been observed as a trimer in both in vivo and in vitro experiments. The assembly of OmpF
monomer into oligomers was observed in MT1 and MT3 bilayers (Systems 1, 2, 3, and 6). In
systems with LPC outer leaflet (Systems 4, 5 and 7), the diffusion of OmpF monomers at 310 K
was limited and even with 48 µs of simulation time, stable dimers or trimers were observed. This
implies that we will need to perform these simulations at a higher temperature (T> Tm) and for
longer times.

However, formation of oligomers is not restricted to a specific membrane

composition. In fact, OmpF oligomers were observed in symmetric phospholipids membranes that
we tested (Figure 4-16). In addition, there have been reports of OmpF assembly in asymmetric
lipopolysaccharide membranes,56 vesicles, and detergents.22 The lack of preference for a
membrane environment suggests that the surrounding lipids do not provide the required stability
to the OmpF monomer to thwart oligomerization.

A
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B

C
Figure 4-16. Dimer formation in different membranes. A). Dimerization of OmpF monomers in 1Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) bilayer (OmpF: cyan, NH3+, PO4-:
pink, acyl chains: white). B). Dimerization of OmpF monomers MT1 bilayer (OmpF: cyan, SYB,
XYA: yellow, acyl chains: white, DPPE: orange). C). Dimerization of OmpF monomers in MT3
bilayer (OmpF: cyan, SYB, XYA: yellow, acyl chains: white, DPPE: orange, POPG: blue, CDL2:
magenta).
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4.5

CONCLUSIONS

The dynamics of OmpF trimer assembly in E. coli outer membrane were studied in coarse-grained
molecular dynamics simulations. Motivated by the importance of bacterial membrane lipids in
protein assembly, we developed a coarse-grained parameter set for E. coli membrane lipids.
Membrane properties such as area per lipid, hydrophobic thickness, and phase transition
temperature were benchmarked against available experimental and computational data.
Development of the coarse-grained lipids was crucial in avoiding the computational bottleneck
involved in long timescale self-assembly simulations. Multiple simulations starting from OmpF
monomers embedded in asymmetric membrane were performed to determine the mechanism and
thermodynamics of the OmpF assembly in bacterial outer membrane. Simulations revealed two
key steps in OmpF trimer formation. In the first step, two monomers interact via specific
complementary protein-protein interfaces to yield an asymmetric dimer, with a −26±1 kcal mol−1
free energy change. The root-mean-square fluctuations of the dimer residues show flexibility in
loop regions, especially in the L2 latching loop, suggesting that the dimer is not fully structurally
stabilized via the single protein-protein interface. In fact, the partially stable dimer acts as a
template for the attachment of a third OmpF monomer that yields a C3 symmetric trimeric
structure. Formation of the trimer from the dimer and a monomer is the second step of the OmpF
oligomerization process and it is associated with a −56±1 kcal mol−1 free energy change. The selfassembled trimer showed excellent agreement with the X-ray crystal structure of OmpF trimer
with a global root-mean square deviation of less than 2.2 Å. Based on thermodynamic data of the
two-step assembly process, an alternate path to trimer formation is presented which involves
interaction of two dimers in the second step. Although a dimer-dimer interaction did not yield a
trimer in our current set of simulations, likely due to limited simulation time, such a step is
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thermodynamically feasible with an associated −30 kcal mol−1 free energy change. Overall, we
observed that OmpF porins self-assemble to form dimeric and trimeric structures in lipid
microenvironments, and oligomerization is not restricted to a specific membrane composition.
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CHAPTER 5

The mechanism of antimicrobial activity of choline-based ionic
liquids (CAGE)

* Permission granted by Kelly Ibsen to use the text of published article below in this chapter.
Ibsen, K. N.; Ma, H.; Banerjee, A.; Tanner, E. E.; Nangia, S.; Mitragotri, S., Mechanism of Antibacterial Activity of Choline-Based
Ionic Liquids (CAGE). Acs Biomaterials Science & Engineering 2018, 4(7), 2370-2379.
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5.1 ABSTRACT
The continued emergence of antibiotic-resistant organisms has severely depleted our arsenal of
effective antimicrobials. Ionic liquids (ILs), or molten salts, and their close relatives, deep eutectic
solvents (DESs), show great promise as antibacterial agents. Understanding the mechanism by
which ILs and DESs attack bacterial cells is key to ensuring that design of IL-based biocides impart
maximum efficacy with minimal toxicity, while also avoiding the potential for the target organisms
to become resistant. Here we report the antibacterial attributes of a set of choline and geranic acid
(CAGE)-based ILs and DESs and identify the mechanism by which they interact with the Gramnegative cell wall of Escherichia coli. Four CAGE variants with varying ratios of choline and
geranic acid were synthesized and tested for their antibacterial activity (1:4, 1:2, 1:1 and 2:1
choline:geranic acid). The minimum bactericidal concentration required to kill E. coli correlated
with the geranic acid content. Using molecular dynamics (MD) simulations, we identified the
mechanism of CAGE action on the E. coli membrane, namely that choline is attracted to the
negatively-charged cell membrane and consequently inserts geranic acid into the lipid bilayer. This
study provides the fundamental mechanism of the action of choline-based ILs on bacteria, and
demonstrates the promise of CAGE as a powerful antimicrobial agent.
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5.2 INTRODUCTION
Ionic liquids (ILs), also known as molten salts, are a broad class of compounds most commonly
described by their low melting points (<100 °C) and low volatility. Common IL cations
(imidazolium, pyridinium, ammonium and phosphonium) can be combined with a variety of
anions, all of which can be further functionalized, to create a diverse set of compounds. Over the
last two decades, ILs have become popular as green alternatives to volatile organic solvents used
in the chemical industry. 1
ILs have been recognized as effective disinfectants for almost a century, but their systematic
investigation as antibacterial and antifungal agents is a relatively new phenomenon. In 1996
Pernak and Skrzypczak reported a correlation between the concentration of an imidazolium
chloride IL and its minimum inhibitory concentration against bacteria.2 Other studies followed to
confirm this relationship and provide a second mechanistic hypothesis, namely that an IL’s
antibacterial activity is correlated with the chain length of its alkyl chain.3-9 Several studies
postulated that aliphatic chains of ILs insert into the bacterial membrane with a mechanism similar
to that used by surfactants or pesticides. Other studies attributed the functionality of ILs to the
inhibition of acetylcholinesterase because of the cation.10, 11
Molecular dynamics (MD) simulations have been used to gain insights into the action of select
imidazolium ILs on model lipid bilayers.12-14 These simulations showed that imidazolium cations
interact with the polar head groups of the lipids and insert their hydrophobic tails into the
membrane. The interactions, however, are highly dependent on the charge and structure of the
cation, the counter anion, as well as the complexity of the membrane lipids. Literature studies on
ILs have focused on simple phospholipid bilayer models as surrogates for bacterial membranes
due to the lack of available force fields for the Gram-negative bacterial outer membranes.
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Moreover, the atomistic MD simulations have been limited to short timescales (hundreds of
nanoseconds) that are unable to provide adsorption kinetics of an IL cation on bacterial
membranes. In recent years, there have been advances in coarse-grained force field libraries for
bacterial membranes that can aid in elucidating the IL-induced morphological reorganization of
the bacterial membranes.15-19
Despite experimental and computational investigation into the interaction of ILs with lipid
membranes, the exact molecular mechanism remains unknown, including the secondary effects of
membrane disruption on cellular signaling and other cellular functions.20 The lack of a complete
mechanistic description hampers the effective development of antimicrobial ILs, especially as it
pertains to avoiding imparting resistance. Combining a full mechanistic knowledge with the fact
that IL properties (hydrophilicity, hydrophobicity, density, viscosity, conductivity, and polarity)
can be widely and readily tuned could provide a wealth of new IL-based antimicrobials with
maximum efficacy and minimum toxicity.
Using a combination of experimental and simulation techniques, we investigated the antibacterial
activity and mechanism of a set of choline (or cholinium)-based ILs on a Gram-negative bacterium,
Escherichia coli. While imidazolium and pyridinium-based ILs are widely used as solvents,
choline, a quaternary ammonium cation, is generally regarded as more benign, and therefore a
good choice for antibiotics. Studies have reported antibacterial properties of choline-based ILs and
deep eutectic solvents (DESs, a mixture of charged and neutral species), using a variety of
counterions or functionalizing the choline cation.6,7,21,22,23 Using geranic acid, a highly
hydrophobic molecule with an 8-carbon backbone, as a counterion, we synthesized 4 cholinegeranic acid (CAGE) formulations, varying the choline bicarbonate and geranic acid ratio: 1:4,
1:2, 1:1 and 2:1. The 1:1 CAGE is a true IL, while the other 3 are DESs composed of a cation:anion,
129

choline:geranate pair plus additional neutral species, either geranic acid (1:4, 1:2) or choline
bicarbonate (2:1). Each variant was tested to determine the minimum concentration required to kill
E. coli, and MD simulations were performed to compute the interfacial properties of CAGE
variants with E. coli, as well as choline bicarbonate, pure geranic acid, and sodium-substituted 1:4
CAGE.

5.3 METHODS
A cuboidal simulation box comprising of two coarse-grained membrane patches (10×10 nm2) in
the xy-plane with 81 LPC (lipid A and core oligosaccharides without o-antigen) and 243 DPPE
lipids each were built using a locally modified version of membrane generator script called
insane.24 The two membranes were stacked along the z-direction (4 nm spacing) with the LPC
leaflets oriented towards the center of the box. The intermembrane space was filled with CAGE
and the remainder of the simulation box was solvated with explicit coarse grained MARTINI
water.25 The CAGE components were coarse grained using the PyCGtool and the MARTINI fourto-one mapping protocol.26,27 The electroneutrality of the system was maintained using hydrated
Ca2+counterions. The two-membrane setup was adopted to compartmentalize CAGE toward the
outer LPS leaflet to mimic experiments and prevent issues that may arise due to periodic boundary
conditions along the z-direction. The simulation setup was repeated for all seven CAGE variants.

The GROMACS molecular dynamics package (version 5.1.2) was used to perform all
simulations.28,29 Energy minimization was performed using the steepest-decent algorithm with a
20 fs time-step until the maximum force on any bead was below the tolerance parameter of 10
kJmol−1nm−1.30 Periodic boundary conditions were applied in all three dimensions. The NVT
(constant number of particles, volume, and temperature) and NPT (constant number of particles,
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pressure, and temperature) equilibration runs were performed for 0.2 µs. Semi-isotropic pressure
coupling was used, and systems were maintained at 1 bar using the Berendsen barostat with time
constant, τp = 4.0 ps.31 Temperature was maintained at 335 K by independently coupling the lipids,
and the solvent to an external velocity rescaling thermostat with τT = 1.0 ps. The neighbor list was
updated every 25 steps using 1.4 and 1.2 nm for short-range van der Waals and electrostatic
cutoffs, respectively. The production NPT simulations were performed for 8 µs or 16 µs for all
systems.

Post simulation analyses were performed using in-built GROMACS utilities and in-house python
scripts. To quantify the CAGE and the membrane interaction, we developed an in-house script to
compute the number of contacts that CAGE components make with E. coli membrane. In this
analysis, we defined the entire E. coli membrane as one unit, which includes β-(1→6)-linked Dglucosamine disaccharide head group linked to six acyl carbon chains, the core oligosaccharide
domain and the lower phospholipid leaflet. A contact was counted when a CAGE component
molecule was within a 1.1. nm cut-off distance with any part of the membrane. Molecular
visualization and graphics were generated using visual molecular dynamics (VMD) software.32

5.4 RESULTS
The MD simulations were performed in the coarse-grained representation to provide a long
timescale comparison of CAGE penetration and partitioning in the E. coli outer membrane. The
MD simulation results show that the choline geranate pair has a unique cooperative penetration
profile into E. coli membranes. The quaternary ammonium choline cation with its short hydroxyl
alkyl chain is sufficiently small to penetrate the LPS domain and form stable ionic interactions
with the negatively charged membrane. The presence of choline also facilitates the penetration of
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geranate, which acts as short chain fatty acid chain and inserts itself into the lipid A tails. The
negatively-charged head group of geranate remains above the hydrophobic tails and is stabilized
by the embedded cholines.
Focusing on the simulation results of choline bicarbonate and 2 CAGE variants—choline
bicarbonate, 2:1, and 1:1 (i.e. without free geranic acid), it is clear that the positively charged
choline easily penetrates the E. coli’s membrane and binds to the negatively charged core and lipid
A head groups. The simulation snapshots (Figure 5-1) of the three variants show that in each case,
choline is trapped within the negatively charged core and lipid A head groups. A higher choline
concentration in 2:1 variant leads to higher density in the core LPS head groups (Figure 5-1b). It
is evident from the geranate density profiles of geranate that it penetrates the outer LPS leaflet
(Figures 5-1 b-c). The contact plot shows how CAGE components penetrate the membrane as a
function of time. In the beginning of the simulation, most of the CAGE components are on the
surface so there are fewer contacts, and as time goes by, the CAGE components disperse into the
membrane, creating more contacts. The CAGE-membrane contact analysis shows as choline
continues to penetrate the membrane until equilibrium is achieved in 6-7 µs. Compared to choline,
the geranate contacts are 6 to 8 times lower in 2:1 and 1:1 CAGE, respectively. Unlike geranate,
the bicarbonate ion, devoid of the alkyl chain, does not penetrate the LPS (Figure 3a), which
explains the limited efficacy observed in experiments.
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Figure 5-1. Comparison of CAGE variants (a) Choline bicarbonate (b) 2:1 and (c) 1:1. For each
variant, the panels show the molecular simulation box, the number density of choline, the number
density of bicarbonate or geranate, and the number of contacts as function of simulation time.

In the case of 1:2 and 1:4 CAGE variants, in addition to choline and geranate, the uncharged
geranic acid molecules penetrate both the outer and inner leaflets of the membrane (Figures 5-2 ab). The abundance of geranic acid in 1:4 CAGE results in very high membrane penetration, which
explains the high efficacy observed in experiments (Figure 5-2b). The geranic acid penetration in
1:2 CAGE is only half of that observed in 1:4 CAGE (Figure 5-2a). However, in the absence of
choline, the penetration of pure geranic acid is drastically reduced (Figure 5-2c).

133

Figure 5-2. Comparison of CAGE variants (a) 1:2 (b) 1:4, and (c) pure geranic acid. For each
variant, the panels show the molecular simulation box, the number density of choline, the number
density of geranate, the number density of geranic acid, and the number of contacts as function of
simulation time.

To further investigate the role of choline, we tested a 1:4 CAGE variant in which choline was
replaced with Na+ ions (Figure 5-3). Just as choline, the Na+ ions penetrate the LPS core and make
similar contacts with the membrane lipids, but being a hard cation, Na+ ions do not interact
cooperatively with softer anions such as geranate and geranic acid molecules to facilitate their
penetration. The substitution of choline with Na+ demonstrate that choline is vital for the
penetration of geranate and geranic acid.
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Figure 5-3. Comparison of Na+ 1: 4 Sodium Geranate. The panels show the molecular
simulation box, the number density of Na+ ions, the number density of geranate, the number
density of geranic acid, and the number of contacts as function of simulation time.

5.5 DISCUSSION
A full understanding of how a candidate antibiotic acts against a pathogen is of upmost importance
to develop antibiotics with high efficacy and low potential to impart resistance. Since the properties
of ILs can be finely tuned, a full mechanistic knowledge of their action of cell disruption can allow
us to the design a wealth of IL-based antimicrobials. CAGE ILs and DESs are easily synthesized
via an ambient temperature salt metathesis reaction using commercially sourced and FDA-listed
GRAS reactants choline bicarbonate and geranic acid. Choline is a water-soluble essential nutrient,
made in the liver, and present in phospholipids that are abundant in cell membranes. Geranic acid,
commonly used as a flavoring agent, is naturally occurring in lemongrass, which has reported
antimicrobial activity itself.33
Mechanistic hypotheses for ILs’ antibacterial activity most commonly include cell membrane
disruption.4,8,9,20 Some studies suggest additional signal interruptions as a result, but what actually
causes cell death remains unknown. The E. coli outer membrane is comprised of a
lipopolysaccharide-rich outer leaflet and a 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine
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(DPPE)-rich inner leaflet. Each E. coli lipopolysaccharide molecule has a core oligosaccharide
domain and lipid A domains with six and two negative charges, respectively.19 The presence of a
negatively charged outer leaflet makes the bacterial membrane unique compared to phospholipid
bilayers and makes it susceptible to penetration by CAGE. In the MD simulations, the density
profiles and the contact analysis of the seven compounds demonstrate that the negatively charged
LPS core forms a barrier for geranate and geranic acid. In the presence of choline-containing
CAGE variants, however, the LPS negative charge is effectively screened and choline is able to
facilitate the geranate and geranic acid penetration into the membrane. Among the seven
compounds simulated, 1:4 CAGE has the highest penetration, which explains the high toxicity
observed in the experiments. Using the CAGE component penetration as a measure of their
efficacy, the simulation results show the following order of CAGE variants toxicity: 1:4 > 1:2 >
1:1 > 2:1> choline bicarbonate > pure geranic acid > Na+1:4. The order corroborates with the
experimentally observed CAGE toxicity.
There are no previous studies on cholinium-geranic acid salts, however some groups have
investigated other choline-based ILs for their bacterial activity, and our results are generally
consistent with these studies. Petkovic, synthesized a group of ILs using a choline cation paired
with a range of linear alkanoate anions ([CnH2n+1CO2]-, where n=1-9) and found that the longer
anion chains resulted in lower MFC values. Choline chloride, tested as a proxy for the choline
cation alone, showed the lowest toxicity.7 Zhao synthesized a variety of choline-based DESs using
choline chloride and several different types of hydrogen-bond donors including organic acids,
amines, alcohols and sugars; only the organic acid-containing DES showed bacterial inhibition.23
The CAGE mechanism of membrane attraction and insertion, while similar to those suggested for
cation-substituted ILs, has a unique feature – the hydrophobic long chain can dissociate from the
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more bulky, hydrophilic cation and penetrate deeper into the membrane. This dissociation ability
may prove useful in developing highly effective antimicrobial ILs. It is also interesting to note that
geranic acid is structurally similar to free fatty acids, which have demonstrated bioactivities related
to chain length and degree of saturation, but poor solubility.34 Combining choline, a hydrophilic
molecule, with hydrophobic geranic acid may improve its ability to contact cells in aqueous
environments like wounds.

5.6 CONCLUSIONS
By varying the ion ratios in CAGE, we were able to show that increasing the geranic acid content
increases the biocidal activity. Through MD simulations we identified cell membrane disruption
via choline attraction to the negatively-charged cell membrane and geranic acid insertion as a
disrupting mechanism. Overall, this study provides the basic mechanism for choline-based IL
activity on the cell membrane of Gram-negative E. coli. CAGE is a promising new antibacterial
that kills E. coli with low mM concentrations and exhibits no evidence of imparting vertical
evolution-based resistance.
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CHAPTER 6

A computational platform for accelerating antibiotics discovery
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6.1 ABSTRACT
Antibiotic resistance has become one of the greatest challenges. Finding new class of antibiotics
is becoming more urgent when Gram-negative bacteria are becoming more resistance to most
available antibiotics. The cell envelope of Gram-negative bacteria contains porin proteins, which
are specific to a few molecules. Understanding molecules transport is urgently needed for the
rational design of existing and new antibiotics. To quickly and accurately obtain the transport
pathway of a large set of small molecules, we built a high throughput computational automated
screening platform. We used P.aeruginosa as the first test of our platform. P.aeruginosa has an
even narrower outer membrane porins, which make penetration of antibiotics harder. The transport
of Carbepenem across P.aeruginosa’s major channel, the OccD1, was studied. The detailed
transport process of Carbepenem was revealed and compared with some reported results. Based
on the fast and accurate information acquisition ability, the computational platform, which can be
used to process large numbers of small molecules and extended to more bacterial membrane as
well as their all identified porins. These results and the platform will help understand the
permeability of drug candidates and facilitate the drug discovery process.
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6.2 INTRODUCTION
Antibiotic resistance has become one of the biggest threats to human health. Even though the
occurrence of antibiotic resistance is a natural process, the overuse and misuse are becoming the
primary reasons for accelerating this process to causes higher patient mortality and treatment
expenses.1, 2 However, the development of new antibiotics cannot catch up with the emergence of
resistant bacteria. Since the last discovery of a new class of antibiotics was on 1987, there is a
huge void in the history of antibiotics development.3 Many major pharmaceutical companies are
dropping antibiotics development programs now, the low success rate makes the cost higher than
expectation, antibiotics resistance develops fast after new antibiotics being introduced, which
makes antibiotics a short-term drug and profits are also reduced. The development of new
antibiotics needs at least 10 years and over 1 billion dollars, potential antibiotics need to be
screened out from more than thousands of small molecules, there is a lack of efficient screening
technique, which can help lower the investment.4 This technique should be able to easily acquire
the antibiotics transport pathway through the bacterial membrane in a fast manner because the
membrane has been proved to be the main barrier for most small molecules. It is worth noting that
Gram-negative bacteria are becoming resistant to most available antibiotic drugs. The complicated
outer membrane of Gram-negative bacteria was found to be able to help them develop antibiotic
resistance easily and quickly.2
The outer membrane of Gram-negative bacteria comprises lipopolysaccharides (LPS) as outer
leaflet, mixture of phospholipids as inner leaflet and outer membrane proteins (OMPs) as pores to
allow transport of small molecules. The rigid outer membrane forms the first line of defense, which
makes the Gram-negative bacteria much harder to treat than Gram-positive bacteria.5-7
Understanding the interactions between this unique membrane and small molecules is essential to
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guide the development process of new antibiotics. To achieve this goal, many potential candidates
need to be tested from some small molecules libraries, e.g. Microsource SPECTRUM Collection,
ChemBridge Diversity Set Library, etc. To facilitate this process, computational approaches
should be employed to comprehensively understand the details at the molecular level and screen
out the most promising antibiotics from these drug candidates to boost the drug discovery pipeline.
Recently, with the development of Computer-aided drug design (CADD), computational
approaches have been widely used to guide and accelerate the early-stage development of new
compounds and reduce the cost.8,

9

Molecular dynamics (MD), which is a computer-based

simulation method to study chemical systems and provide physical behavior of each atom or
molecule in the system for nanoseconds to microseconds, can be employed to gain insights into
the actions of small molecules on bacterial outer membrane or membrane proteins in molecular
level to help develop robust antibiotics.5-7, 10
All-atom MD and Coarsed-grained MD are being widely used to perform simulations. All-atom
MD provides us detailed interactions between each atom but needs more computing resources and
time, so it is too expensive for All-atom MD to achieve long simulation time and simulate
complicated systems. MD in coarse-grained (CG) level could help achieve longer time scale and
larger system sizes by merging several atoms into one bead to reduce the degree of freedom so
that people can explore more complex systems.11-14 Martini force field is a popular used CG force
field that provides us a variety of parameters of LPS, membrane lipids, amino acids, proteins,
solvents and ions.15-21 We built our CG representation of simulation systems using Martini force
field, comprising Gram-negative bacterial outer membrane with or without OMPs embedded
depending on the specific bacteria, target molecule and solvents to explore the exhaustive transport
behavior of target molecule through the membrane or OMPs into the periplasmic space. The
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thermodynamic and kinetic data of the transport can be obtained by our CG molecular simulations
as well as the molecule-membrane/molecule-protein interactions. To alleviate the burden of
building new systems with different bacteria membranes, OMPs and small molecules, we made an
automatic simulation control algorithm to easily achieve our goals, which is a computational
automated screening platform that can quickly generate the data for further analysis. However, to
validate the reliability of the computational platform, we had to prove that the simulation results
could reproduce bench experimental or atomistic simulation data.
What we noticed was, the outer membrane carboxylate channel D (OccD), the largest family of
substrate-specific proteins in P. aeruginosa, has been well studied in recent years.22-27 OccD,
known as the main channel for majority of small molecules such as basic amino acids, is a barrel
protein with 18 β-strands connected by large extracellular loops and short turns and its x-ray
structure has been determined. Additionally, OccD1 is the important gateway for carbepenem
antibiotics, which are being widely used to treat infections caused by P. aeruginosa.28,

29

Carbepenems belong to β-lactam antimicrobial agents, which are able to bind the penicillin binding
proteins (PBPs) to inhibit P. aeruginosa’s cell wall synthesis. The advantage of using
Carbepenems is their excellent stability against most β-lactamases.30, 31 However, P. aeruginosa
acquires resistance against carbepenems by changing their PBPs’ structure, expressing efflux
pumps and lower their OccD protein’s permeability or stopping expressing these specific porin
proteins.32-34 Understanding the mechanism of Carbepenems’ transport is imperative to reduce the
threat of P. aeruginosa, which has been listed as the top 3 pathogenic bacteria by World Health
Organization in 2017. Recently, the penetration of Carbepenems across P. aeruginosa’s OccD1
protein has been studied in detail, elaborating the specific penetration process, which could be used
as benchmark to validate the accuracy, reliability and feasibility of our computational platform
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when CG force field parameters of P. aeruginosa are already available, which was done by our
previous work.5, 25, 31
In this work, we reported the development of a novel computational automated screening platform
(CLASP) for small molecules screening. Six carbepenems including doripenem, ertapenem,
biapenem, panipenem, meropenem, imipenem and OccD1 porin protein of P. aeruginosa were
chosen as the first test for our newly built CLASP (Table 6-1). After 6 independent simulations,
the 6 carbepenems showed excellent behavior of penetration profiles, which reproduced the
experimental findings and provided more insight into the penetration process within a very short
time. Based on our performance tests, each simulation can be finished within 45 minutes using our
available computer resources and could be reduced when adopting high performance computing.
Our results provided an automated computational platform for exploring penetration process of
small molecules, which can be applied to all CG lipid bilayer and available bacterial outer
membranes, atomistic models are applicative by mapping to CG modeling using martinize.py18
and PyCGTOOL.35 This platform developed a new method of optimizing lead compounds and
breaking through the obstacle of finding effective antibiotics.
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Background Information
Doripenem

Ertapenem

Biapenem

Panipenem

Meropenem

Imipenem
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6.3 METHODS
6.3.1 Simulation details
Simulation set-up: The GROMACS molecular dynamics package (5.1.2) was used in the present
work.36 Energy minimization simulations were performed using the steepest-decent algorithm with
a 20 fs time-step until the maximum force on any bead was below the tolerance parameter of 10
kJ mol−1 nm−1.37 Periodic boundary conditions were applied in all three dimensions. The NVT
(constant number of particles, volume, and temperature) and NPT (constant number of particles,
pressure, and temperature) equilibration runs were performed for 0.2 µs.38,

39

Semi-isotropic

pressure coupling was used and systems were maintained at 1 bar using the Berendsen barostat
with time constant, τp = 4.0 ps.40, 41 Temperature was maintained at 325 K by independently
coupling the lipids, proteins, and the solvent to an external velocity rescaling thermostat with τT =
1.0 ps. The neighbor list was updated every 25 steps using 1.4 and 1.2 nm for short-range van der
Waals and electrostatic cutoffs, respectively. The production NPT simulations were performed for
2 µs.
Potential of Mean Force (PMF) Calculations: To compute the PMF curves, we built the P.
aeruginosa lipopolysaccharide with OccD1 porin protein embedded in 10×10 nm2 membrane
patches. The membrane was equilibrated while keeping the proteins position-restrained for 0.5 µs
at 310 K. The restraints were then removed and pull simulations were performed along the reaction
coordinate defined by separation of the center of mass (COM) of the interacting OccD1 while still
embedded in the membrane. A single diglycine was pulled with respect to the COM of its positionrestrained OccD1 protein. A harmonic potential with 5000 kJmol-1 nm2 force constant was used
for the pull. A total of 100 independent Umbrella Sampling (US) windows were extracted along
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the reaction coordinate for both systems, and each window was simulated for 0.2 us. The weighted
histogram analysis method (WHAM) along with bootstrapping was used to extract the PMF
profiles.42
Table 6-1 System details of Carbepenem-OccD1 simulations
Antibiotic
Doripenem
Ertapenem
Biapenem
Panipenem
Meropenem
Imipenem

Inner
DPPE
144
144
144
144
144
144

Outer
LPA
DPPE
55
6
55
6
55
6
55
6
55
6
55
6

carbepenem
1
1
1
1
1
1

No. of
OccD 1
1
1
1
1
1
1

water
6507
6507
6507
6507
6507
6507

ions
127
127
127
127
127
127

T (K)

t (s)

325
325
325
325
325
325

200
200
200
200
200
200

6.3.2 Method development
The CLASP algorithm has been developed to accelerate the simulation process for calculating
PMF using Martini Force Field and subsequent data processing and analysis. The aim is to make
the tedious Umbrella Sampling simulations automated and quickly obtain some important
biological data. Although the CLASP was designed for CG simulations, atomistic models are also
supported by converting to CG model using Martinize or PyCGTOOL. The work flow is shown
in Fig.6-1.
Atomistic or Coarse grain structure of proteins and molecules as well as the topology are taken as
the input files, different kinds of membrane can be built by insane.py with interested proteins
embedded,43 10 Gram-negative bacterial outer membrane can be also generated using in-house
modified insane.py called BOB.py (Bacterial Outer membrane Builder). A short Energy
minimization, NVT and NPT are needed after building the membrane-protein-solvent system
followed by a 2 μs production NPT simulation to establish the starting configuration. The pre-
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prepared molecules input files are inserted into the well-designed N positions across the protein
channel to generate N configurations by gmx insert-molecules. Each one will be taken as the
starting configuration for the US window and will be assigned an independent directory to perform
US run. Finally, the PMF curves will be generated and trajectories will be used for further analysis
to obtain useful biological information.

Figure.6-1 CLASP workflow
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6.3.3 CLASP performance
In this work, all simulations were performed in GROMACS as mentioned in the method. The
performance is provided for The Academic Virtual Hosting Environment (AVHE) computer
clusters provided by Syracuse University. Table 2 shows the performance for different number of
nodes and openMP threads used for the umbrella sampling simulations. The best performance we
calculated was about 3200 ns/day and only 45 mins are needed for the simulations. With enough
nodes provided, our platform can be used in a very fast manner.
Table 6-2 Simulation Performance
# of Nodes
2
4
8
16
24
24
24

# of OpenMP
2
2
2
2
1
2
3

Rate (ns/day)
637.775
889.276
1875.672
1847.037
2346.15
3202.917
2207.56

Time (mins)
225
161
76
77
60
45
65

6.3.4 Carbepenem coarse graining
The coarse grain parametrization of carbepenem was developed based on MARTINI many to-one
mapping in which on average four heavy atoms are mapped into one bead. The detailed mapping
scheme of six carbepenem were shown in Fig.6-2. The β lactam ring was assigned four beads (SP1,
SP3, SC5, SQa) and the side chain linked to β lactam ring through a sulfur was assigned different
beads types based on each one’s specific side group. PyCGTOOL was used to generate the initial
system coordinates and topologies for CG simulations. The validation was also performed to
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compare the CG model with the atomistic structure using PyCGTOOL tutorial to ensure the high
quality of the CG model.
A.

B.

C.

D.

E.

F

Figure.6-2 The coarse grained mapping scheme showing Martini beads of types Q/SQ (cyan), P/SP
(orange), C/SC (grey), N/SN (green), A) Doripenem B) Ertapenem C) Biapenem D) Panipenem
E) Meropenem F) Imipenem
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6.3.5 Analysis
Post simulation analyses were performed using CLASP data analysis scripts including some inbuilt GROMACS utilities, and external software suites such as YASARA for protein alignment
with X-ray crystal structure and CAVER for analysis and visualization of porin channels.
Molecular visualization and graphics were generated using VMD, PyMol and YASARA.44-47

6.4 RESULTS
In this work, we showed the ability of CLASP to obtain the transport barrier of small molecules,
interactions between small molecules and channel proteins, key residues involved during transport
and the orientation of small molecules during the whole transport process. We used our selected 6
carbepenem as examples. Based on the size and coarse grain mapping of these 6 carbepenem, I
categorize them as 1) Doripenem and Ertapenem, which have 7 and 8 beads, respectively 2)
Panipenem, Meropenem and Biapenem, which contain 6 martini beads and 3) Imipenem, which
only has 4 beads.
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Case study 1: Doripenem and Ertapenem
The PMF profiles of the six-selected carbepenems were obtained using the automated umbrellasampling simulations implemented in CLASP. One hundred of configurations were generated
along the OccD1’s channel and run in independent simulations. All simulations were performed
while the protein was embedded in P. aeruginosa’s lipidA-phospholipid membrane. The free
energy profiles of Doripenem and Ertapenem carbepenem were shown in Fig.6-3. There is a
common binding site around Displacement (D) = 2.3 nm for Doripenem and Ertapenem, which is
the landing site of carbepenem in the entrance of OccD1’s channel that right above loop 7. The
region from D= 2.5 nm to D= 4.7 nm was found to be the constriction zone of OccD1, which has
narrower cavity compared with other regions of the protein. Doripenem and Ertapenem showed
transport barrier about 52 and 48 kJ/mol to go through this highly confined region.

Figure.6-3 PMF of Doripenem (Navy blue) and Ertapenem (red)
The PMF profile of Doripenem and Ertapenem showed us two interesting sites inside the protein,
D= 2.3 nm and D= 4 nm. At D = 2.3 nm, both of them had favorite binding sites due to the
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formation of some intermolecular interactions. Doripenem and Ertapenem have energy well-depth
of ~ 8 kJ/mol and ~17 kJ/mol, respectively, which shows that Ertapenem has stronger binding
affinity towards this landing site of OccD1.
The detailed transport process of carbepenem have been studied over the past few years. It is well
known that carbepenem need the assistant of some specific amino acids to successfully transport
through the OccD1, the functions of arginine ladder has been studied carefully recently to reveal
the importance of it to mediate the penetration of carbepenem. Arginine would interact with the
carboxylate of carbepenem to stabilize the binding of carbepenem and OccD1. The arginine ladder
includes Arg 30, Arg 39, Arg 319, Arg 337, Arg 389, Arg 391 and Arg 410, which extend through
the constriction zone, would guide the permeation of carbepenem toward the inside of OccD1,
leading to a successful penetration. In order to prove the importance of the arginine ladder during
the carbepenem’s penetration, CLASP was designed to be able to catch the interactions between
small molecules and amino acids of the protein channel in a dynamic way and give us a
comprehensive view of the transport process, which is an important function to find out the most
important residues that can facilitate the transport process or block the penetration so that we can
modify or design small molecules on a basis of these results. Here we report the application of
CLASP to capture how small molecules contact with all amino acids of the protein to reveal the
participation of arginine ladder in carbepenem penetration.
Firstly, the trajectories of Doripenem and Ertapenem penetrating the OccD1 were generated and
then analyzed by CLASP to calculate the contact or collision between them and the amino acids
of OccD1. The contact was calculated based on the center of mass distance between the them and
the specific amino acids, when the distance was smaller than van der Waals force cut-off (1.2 nm),
they would be recognized as having contact. By using this method, the total number of contacts
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between the Doripenem and Ertapenem molecule and all amino acids of OccD1 were recorded.
The most notable six amino acids that have the highest number of contact were shown in Fig.6-4
for Doripenem and Ertapenem. It showed that Tyr, Arg and Phe had the most significant contact
with Doripenem and Ertapenem. During penetration, doripenem and Ertapenem molecule would
make significant contacts with tyrosine first followed by very frequent contacts with arginine
Phenylalanine also showed high contact because most phenylalanine within OccD1 are adjacent
to arginine so they showed similar contact. These results highlighted the important amino acids
involved during the penetration, modifications or mutations of these amino acids may lead to
different pathway and permeability.
A

B

Figure.6-4 Amino acid – Carbepenem contacts A) Doripenem B) Ertapenem. Tyrosine (blue),
Arginine (red), Phenylalanine (yellow), Threonine (green), Histidine (light green), Lysine (orange)

However, this was still not enough to understand which Tyrosine and Arginine made contributions
to the contact. Even though it was notable that tyrosine and arginine were critical during the
penetration process. However, OccD1 includes 26 tyrosine and 16 arginine, not all of them were
involved in this process. In order to identify the specific tyrosine and arginine involved, CLASP
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was designed to be able to obtain the contact between the carbepenem molecule and tyrosine,
arginine of OccD1, respectively using similar method in last paragraph. This result would provide
us more accurate targets if any modifications or mutations are needed to be done to change
OccD1’s selectively or permeability. Fig. 6-5 shows the total contact between Doripenem and
Ertapenem molecule with all tyrosine in OccD1, the assignment of colors was based on the number
of contacts, tyrosine that has the highest contact with Doripenem or Ertapenem was assigned red,
then we showed gradually decreasing concentrations in green, cyan, navy blue and gray. Tyr 173,
Tyr 176, Tyr 305 and Tyr 359 were the most significant tyrosine to interact with both Doripenem
and Ertapenem. The positions of these 4 red-labeled tyrosine were highlighted in OccD1 in Fig.65 C. Not surprisingly, all red-labeled tyrosine were found at the entrance of OccD1. And the fact
is the entrance of OccD1 shows high density of tyrosine.
More importantly, Fig.6-4 revealed the significant participation of arginine. Similar to the tyrosineDoripenem/Ertapenem contact map above, the 16 arginine’s contacts with Doripenem/Ertapenem
were also recorded. Arg 30, 39, 131, 319, 389, 391 were found to be the most significant residues
to interact with Doripenem and Ertapenem (Fig. 6-6). These residues are located on or near the
basic ladder or opposite. This finding matched the aforementioned reported results about the
arginine basic ladder and confirmed the importance of them.41 Ertapenem showed higher contacts
with tyrosine and arginine due to its bigger size, it contains 8 beads that had higher probability to
have contact with these amino acid residues.
The orientation of Doripenem and Ertapenem during the transport were recorded using CALSP
(Fig. 6-7). The Dij is the z-component of the norm of the interatomic vector connecting the first
SP1 bead on the β lactam ring and the last bead on the side chain (P5 of Doripenem and SP3 of
Ertapenem). The magnitude of this vector is about 1 nm and the direction is from SP1 to Qd for
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panipenem. The magnitude was also calculated to ensure that it would not change during the
process so that its z-component can be used as a good mark for the orientation. Fig. 6-7 showed
the changes of Dij, it was clear that the molecule can move freely in the wide and open regions (D=
0 – 2.5 nm and D > 5nm), but the orientation was restrained in the constriction zone (D= 2.5 – 5
nm). Moreover, for Doripenem, when D= 3 nm, the Dij was mostly negative, indicating the SP1
bead was mostly above the Qd bead, when D was close to 3.8 nm, Dij was close to +1 nm indicating
the Doripenem was almost parallel to the z axis of the protein with SP1 bead ahead, it looks like
that a flip-flop happened around D= 3.7 nm . However, after D= 4nm, there was a sudden change
of the orientation to a negative Dij. When D= 4nm, another flip-flop happened again so the Dij
became negative again. Ertapenem had one flip-flop happened around D= 3.3 nm.
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A

B

C

Figure. 6-5 Tyrosine - Carbepenem contact A) Tyrosine – Doripenem contact B) Tyrosine –
Ertapenem contact C) Positions of tyrosine with highest contact
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A

B

Figure.6-6 Arginine - Carbepenem contact A) Arginine – Doripenem contact B) Arginine –
Ertapenem contact

A

B

Figure. 6-7 Dij of A) Doripenem and B) Ertapenem
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Case study 2: Panipenem, Biapenem and Meropenem
The free energy profiles of Panipenem, Biapenem and Meropenem were shown in Fig. 6-8. These
three carbepenem have similar binding site around D= 2.3 nm. They have intermediate transport
barrier about 28, 23 and 22 kJ/mol, respectively, which are significantly smaller than Doripenem
and Ertapenem. This difference may arise from the bulky side groups that Dorioenem and
Ertapenem have. It is also interesting that all of them showed similar depth of the binding sites
about 15 kJ/mol compared with 29 kcal/mol of panipenem, indicating a possible stronger binding
of panipenem toward OccD1’s binding site at D = 2.4 nm.

Figure. 6-8 PMF of Panipenem (orange), Biapenem (purple) and Meropenem (green)
In order to catch the important residues, the total number of contacts between the Panipenem,
Biapenem and Meropenem molecule and all amino acids of OccD1 were computed as described
in Case study 1 (Fig. 6-9). Same color scheme was used here. It is very clear that tyrosine and
arginine were also the most significant ones as Doripenem and Ertapenem. Because of the smaller
size compared with Doripenem and Ertapenem, less frequent contacts were observed for these 3
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carbepenem. For tyrosine, Tyr 173, Tyr 176, Tyr 305 and Tyr 359 were still found to have the
highest contacts (Fig. 6-10), which also means most carbepenem have similar preferred “landing
site” at the entrance of OccD1. For arginine, Arg 30, 39, 131, 319, 389, 391 that from the arginine
ladder had the highest contact with Panipenem, Biapenem and Meropenem (Figure 6-11).
A

B

C

Figure.6-9 Amino acid – Carbepenem contacts A) Panipenem B) Biapenem C) Meropenem
Tyrosine (blue), Arginine (red), Phenylalanine (yellow), Threonine (green), Histidine (light
green), Lysine (orange)
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A

B

C

Figure. 6-10 Tyrosine - Carbepenem contact A) Tyrosine – Panipenem contact B) Tyrosine –
Biapenem contact C) Tyrosine – Meropenem contact
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A

B

C

Figure.6-11 Arginine - Carbepenem contact A) Arginine –Panipenem contact B) Arginine –
Biapenem contact C) Arginine – Meropenem contact
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The orientation of Panipenem, Biapenem and Meropenem were also computed (Fig. 6-12). The
flip-flop effect was observed in all three carbepenem here. For example, panipenem showed
lumped Dij = 1 around D= 3.6 – 3.8 nm and suddenly below -0.5 around D= 4 - 4.6 nm, indicating
a sudden flip-flop happened during the penetration.
A

B

C.

Figure. 6-12 Dij of A) Panipenem and B) Biapenem C) Meropenem
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In order to catch the orientation change, we extracted the frames from our simulations to show
how panipenem transported through D= 3.6 – 4.6 region. Panipenem molecule, its SP1 bead and
Qd bead were colored skyblue, red and yellow, respectively. The carboxylate group of carbepenem
(SQa bead) was colored magenta and the positively charge nitrogen in arginine’s guanidino group
was colored green to better show the positions of the functional groups. The penetration sequence
was also labeled as 1-5 in Fig. 6-13. When the panipenem molecule was close the constriction
zone when D > 3.6, it maintained the orientation like step 1 and 2 with carboxylate group pointing
to the guanidino group of Arg 131, now the Dij is close to +1. When it was moving deeper, the
opposite arginine would take over the guide function and the panipenem would turn around to face
to these arginine with carboxylate group pointing to their guanidino group (step 3-4). Then they
would still maintain this tailfirst shape due to the restrain of the narrow constriction zone until it
reached the wide region and finally got out of the protein, now the Dij was about -1. The Arg 131
was working as a transfer station when panipenem was guided by previous arginine in the ladder
to the later arginine of the ladder in the narrowest region of the constriction zone. Arg 131 is not
part of the arginine ladder, so its function was rarely investigated in previous studies. By studying
the whole penetration process of carbepenem, its function was partly revealed.
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Figure.6-13 Panipenem penetrating OccD1 constriction zone process. Major arginine involved in
this process are colored red.

Case study 3: Imipenem
Imipenem is the smallest carbepenem among the 6 selected carbepenem. It showed the lowest
barrier of 15.5 kJ/mol (Fig. 6-14). This was correlated with the size of the six carbepenem, based
on Martini Force Field’s mapping scheme, Doripenem and Ertapenem were mapped to 7 and 8
beads, respectively, Biapenem, Panipenem and Meropenem were mapped to 6 beads, imipenem
was mapping to 5 beads (Fig. 6-2). All of them showed no significant barrier after D> 4.7 nm,
indicating a wide and open protein channel after the constriction zone and the main barrier of
OccD1 was at D = 4 nm.
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Figure.6-14 PMF of Imipenem
From Fig. 6-15, it is obvious that tyrosine and arginine were still the leading amino acids that made
the most contact with imipenem. Tyr 173, Tyr 176, Tyr 305 and Tyr 359 had the highest contact
with imipenem (Fig. 6-16 A) and arginine ladder also had high contact with imipenem (Fig. 6-16
B), which remains the same as other 5 carbepenem.

Figure.6-15 Amino acid – Imipenem contacts
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A

B

Figure. 6-16 A) Tyrosine - Imipenem contact B) Arginine – Imipenem contact

The orientation of imipenem during the transport still had less frequent changes in the constriction
zone, but not as obvious as other 5, which may because of the size of imipenem that allowed it to
move more freely in the highly confined constriction zone. Flip-flop of Dij were also observed as
D=3.4–3.6 nm, 3.6-3.8nm and Dij were more negative around D= 4.0 nm.
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Figure. 6-17 Dij of Imipenem

6.5 DISCUSSION
The major applications of CLASP were revealed by the 3 case studies. Transport barriers of six
selected carbepenem were computed using automated Umbrella Sampling simulations conducted
by CLASP. The transport barriers showed positive correlation with the size of the molecule. The
smallest imipenem had the lowest barrier. As D= 2.5 nm all carbepenem have a strong binding site
toward OccD1. All carbepenem showed similar depth of the binding sites below 20 kJ/mol
compared with -29 kJ/mol of panipenem, indicating a possible stronger binding of panipenem
toward OccD1’s landing site of entrance.
We computed the contacts between all amino acids of OccD1 and the six carbepenem. All of them
showed similar contact map without any exception. Furthermore, we noticed that tyrosine showed
significant higher contact with carbepenem when they started entering the channel because of
tyrosine’s high density in the entrance. Even though there is few research on the functions of
tyrosine, the importance of tyrosine during the transport should attract more attention.
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Arginine ladder plays important role in guiding the transport of carbepenem, arginine from the
arginine ladder formed stable interactions with carbepenem and had high contact with them based
on hydrophobic interactions/hydrogen bonding plots and contact map. Besides the arginine ladder,
some other arginine also had high contact with all carbepenem. Arg 131, which is not part of the
arginine ladder, had high contact with all carbepenem and its function was partly studied in this
paper. However, all amino acid residues that are involved during the transport should be studied
carefully. And CLASP is able to catch these important residues accurately and easily. Suitable
mutations of these identified important residues would provide comprehensive understanding of
their features
All 6 carbepenem showed the similar turning behavior, which was achieved with the assistant of
Arg 131, either from tailfirst to headfirst, or from headfirst to tailfirst depending on their initial
orientation before penetrating this area. This finding confirmed the guide function of arginine
ladder as well as the importance of Arg 131. The detailed penetration steps of carbepenem was
also revealed here, which would be important for amino acid mutation study, modification of
available antibiotics and design of new antibiotics.
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6.6 CONCLUSIONS
The spread of resistant bacteria species is becoming uncontrollable in the absence of efficient
platforms for antibiotic discovery. To facilitate the process of finding more promising lead
compounds, CLASP was developed to quickly acquire information about the transport process of
small molecules. P. aeruginosa and its special outer membrane protein OccD1 were chosen as the
first test of this platform. Six carbepenem were used in this test. CLASP was able to obtain the
barrier for these carbepenem transport through OccD1 within 1 hour. During the transport process,
tyrosine and arginine were found to be the most dominant amino acids involved and specific
residues of two amino acids were also identified, further study on these residues would help
understand the functions of them. In order to successfully go through the constriction zone of
OccD1, all carbepenem were guided by the arginine ladder. In this region, the frequency of
molecular directional changes is significantly reduced. Arg 131, as a transfer stop, could cause
sudden directional change, even though it is not part of the arginine ladder, its function cannot be
ignored. These information would guide rational design and modification of antibiotic molecules.
Overall, we successfully designed the CLASP, and it is a promising computational platform for
screening of promising small molecules and facilitating antibiotic discovery.
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CHAPTER 7

CONCLUSIONS AND FUTURE WORK
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7.1 CONCLUSIONS
In this work, force field parameterization of ten Gram-negative bacterial outer membranes has
been completed. Coarse grained computational models of these ten membranes showed great
agreement with experimental data. Force field parameters can be downloaded online now for free
either from our group website or Martini force field website. As an integral part of the cell
membrane, behavior of OmpF porin protein were also studied. The results highlighted the
necessity of OmpF to remain trimeric state. The process of OmpF to form trimer were observed
by simulations. The mechanism of forming trimer was also confirmed.
After successfully modeling Gram-negative bacterial outer membrane, we applied our coarse
grained E.coli’s outer membrane to the study of ionic liquids. Molecular dynamic simulations were
used to reveal the effect of CAGE variants on E.coli’s outer membrane. Combined with
experimental data from our collaborator, basic mechanism of choline-based IL activity was
illuminated. This also confirmed the reliability and applicability of our models.
To best use these models, CLASP was developed to achieve automated screening of antibiotics. 6
carbepenem were chosen as the first test of CLASP. The results basically confirm the previously
published conclusions and provide more valuable information. The easy extension of CLASP
makes it a promising tool to investigate more potential small molecules and help rational design
of available antibiotics. The process of developing antibiotics will benefit from the information
provided by CLASP.
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7.2 FUTURE WORK
Gram-negative and Gram-positive bacteria both have peptidoglycan in their cell wall, which is not
included in my work. Coarse grained parameterization of bacterial peptidoglycan has been partly
done in our group. Mechanism of how antibiotics transport through the entire cell wall of bacteria
can be achieved in the future.
A library of coarse grained bacterial outer membranes are needed to improve the applicability of
CLASP especially for those pathogenic species. Based on available models and identified porin
proteins, CLASP can already be extended to 10 bacterial as well as their associated porin proteins.
We only tested one porin protein of P. aeruginosa, whose major porin proteins are more than 10
types.
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Appendix: Tables of parameters for coarse grained E.coli lipid A and
core oligosaccharides
Table S4-1. Equilibrium bond length and force constant values for the coarse grained lipid A
model of E. coli
Residue
Bonds
Rmin(nm)
Kbond(kJ mol−1 nm−2)
XYA
L1-L3
0.32
5000
XYA
L1-L5
0.32
5000
XYA
L1-L2
0.32
1250
XYA-LP1
L2-L6
0.47
1250
XYA-LP1
L3-L9
0.47
1250
XYA
L4-L1
0.32
5000
XYA
L4-L3
0.32
5000
LP1
L6-L7
0.47
1250
LP1
L7-L8
0.47
1250
LP1
L9-L10
0.47
1250
SYB
L13-L15
0.3
5000
SYB
L13-L16
0.47
5000
SYB-XYA
L13-L4
0.47
5000
SYB
L14-L15
0.47
5000
SYB
L14-L13
0.3
5000
SYB
L15-L17
0.32
5000
SYB-LP3
L15-L28
0.47
1250
SYB-LP2
L16-L21
0.47
1250
LP2
L18-L19
0.47
1250
LP2
L19-L20
0.47
1250
LP2
L21-L18
0.47
5000
LP2
L21-L22
0.47
1250
LP2
L22-L23
0.47
1250
LP2
L23-L24
0.47
1250
LP3
L25-L28
0.47
1250
LP3
L25-L26
0.47
1250
LP3
L26-L27
0.47
1250
LP3
L28-L29
0.3
1250
LP3
L29-L30
0.47
1250
LP3
L30-L31
0.47
1250
LP3
L31-L32
0.47
1250
LP1 (2-hydroxytetradecanoyl acid 14:0); LP2 (dodecanoyl acid decyl ester) ; LP3 (tetracanoyl
acid decyl ester); SYB (3-(acetyl amino)-3-deoxy-D-glucose); XYA(3-(acetyl amino)-3-deoxyD-glucose);
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Table S4-2. Equilibrium angle and force constant values for the coarse grained Lipid A model of
E. coli
Angle
L4-L3-L1
L3-L1-L5
L2-L6-L7
L6-L7-L8
L9-L10-L11
L10-L11-L12
L13-L4-L3
L14-L15-L17
L14-L13-L15
L14-L15-L13
L13-L16-L21
L18-L19-L20
L18-L21-L22
L21-L22-L23
L22-L23-L24
L25-L26-L27
L13-L15-L28
L15-L28-L29
L28-L29-L30
L30-L31-L32

θeq (degrees)
120
120
180
180
180
180
107
87
59
68
180
180
120
180
180
180
101
180
180
180
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Kangle(kJ mol−1)
50
50
25
25
25
25
50
50
50
50
25
25
50
25
25
25
50
25
25
25

Table S4-3. Equilibrium bond length and force constant values for the coarse grained core
oligosaccharide model of E .coli
Residue
GAL
GAL
GAL-2GA
GAL
2GA
2GA
2GA-2GL
2GA
GLC
GLC
GLC
GLC-2GL
2GL
2GL
2GL-3GL
2GL
3GL
3GL
3GL
3GL-2HP
HEP
HEP
HEP-2HP
HEP
HEP
2HP
2HP
2HP-3HP
2HP
2HP
2HP
3HP
3HP
3HP-LKO
3HP
3HP
3HP
OKO
OKO-3HP

Bonds
L1-L2
L1-L3
L1-L4
L2-L3
L4-L5
L4-L6
L4-L10
L5-L6
L7-L8
L7-L9
L8-L9
L7-L11
L10-L12
L10-L11
L10-L14
L11-L12
L14-L15
L14-L13
L13-L15
L15-L23
L16-L18
L16-L19
L16-L21
L17-L18
L18-L19
L20-L22
L20-L23
L20-L28
L21-L22
L22-L23
L23-L24
L25-L27
L25-L28
L25-L34
L26-L27
L27-L28
L28-L29
L36-L35
L35-L27

Rmin (nm)
0.368
0.291
0.321
0.298
0.274
0.372
0.33
0.268
0.286
0.372
0.275
0.352
0.369
0.281
0.341
0.33
0.301
0.365
0.282
0.365
0.319
0.234
0.323
0.287
0.227
0.308
0.272
0.306
0.334
0.387
0.393
0.267
0.309
0.293
0.259
0.316
0.289
0.258
0.262
186

Kbond(kJ mol−1 nm−2)
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000

3HP
3HP
3HP
LKO
3HP
LKO
LKO
LKO
LKO
LKO
LKO-OKO
OKO
OKO
OKO
OKO
OKO

L27-L25
L27-L28
L28-L29
L30-L31
L28-L29
L30-L31
L30-L33
L30-L34
L32-L33
L33-L34
L34-L35
L35-L36
L35-L38
L37-L38
L37-L39
L38-L39

0.248
0.258
0.289
0.239
0.289
0.239
0.216
0.248
0.216
0.258
0.349
0.233
0.21
0.284
0.238
0.242

17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000
17000

LP1 (2-hydroxytetradecanoyl acid 14:0); LP2 (dodecanoyl acid decyl ester) ; LP3 (tetracanoyl
acid decyl ester); SYB (3-(acetyl amino)-3-deoxy-D-glucose); XYA(3-(acetyl amino)-3-deoxyD-glucose); LKO and OKO (3-deoxy-D-manno-oct-2-ulosonic acid) ; HEP or HP (L-glyceroD-manno heptose); GAL or GA (D-galactose); GLC or GL (D-glucose).
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Table S4-4. Equilibrium angle and force constant values for the coarse -grained core
oligosaccharide model of E. coli
Angle
L5-L1-L4
L3-L1-L2
L1-L3-L2
L2-L1-L3
L1-L4-L6
L1-L4-L5
L4-L5-L6
L9-L8-L7
L9-L7-L8
L4-L10-L12
L10-L11-L12
L11-L12-L10
L11-L7-L8
L14-L15-L13
L14-L13-L15
L23-L22-L20
L23-L20-L22
L23-L22-L21
L15-L23-L20
L19-L18-L16
L19-L18-L17
L19-L16-L21
L22-L20-L28
L28-L27-L25
L28-L27-L26
L28-L25-L33
L27-L28-L29
L26-L27-L25
L25-L34-L33
L34-L33-L32
L34-L30-L31
L33-L30-L31
L33-L34-L30
L25-L34-L35
L37-L39-L38
L39-L37-L38
L38-L35-L36
L39-L38-L37

θeq (degrees)
122
52
77
52
116
132
67
79
63
140
73
47
105
77
47
83
63
131
180
70
131
125
122
58
110
112
134
134
91
117
140
106
50
108
52
63
105
110
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Kangle(kJ mol−1)
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
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